Project
avrg: GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Navigation
Downloads
Results for ESRRA_ESR2
Z-value: 3.63
Motif logo
Transcription factors associated with ESRRA_ESR2
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
ESRRA
|
ENSG00000173153.17 | ESRRA |
|
ESR2
|
ENSG00000140009.19 | ESR2 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| ESRRA | hg38_v1_chr11_+_64306227_64306446 | 0.42 | 5.7e-11 | Click! |
| ESR2 | hg38_v1_chr14_-_64294364_64294410 | 0.29 | 1.6e-05 | Click! |
Activity profile of ESRRA_ESR2 motif
Sorted Z-values of ESRRA_ESR2 motif
Network of associatons between targets according to the STRING database.
First level regulatory network of ESRRA_ESR2
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 13.9 | 41.6 | GO:0002086 | diaphragm contraction(GO:0002086) |
| 11.5 | 103.9 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
| 10.9 | 32.6 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
| 9.8 | 714.4 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
| 8.9 | 26.6 | GO:0001869 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 8.8 | 35.2 | GO:1903629 | regulation of calcium-dependent ATPase activity(GO:1903610) negative regulation of calcium-dependent ATPase activity(GO:1903611) regulation of dUTP diphosphatase activity(GO:1903627) positive regulation of dUTP diphosphatase activity(GO:1903629) negative regulation of aminoacyl-tRNA ligase activity(GO:1903631) regulation of leucine-tRNA ligase activity(GO:1903633) negative regulation of leucine-tRNA ligase activity(GO:1903634) |
| 7.9 | 23.8 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
| 7.4 | 22.3 | GO:0071461 | cellular response to redox state(GO:0071461) |
| 6.9 | 27.8 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
| 6.7 | 20.2 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
| 6.3 | 18.9 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
| 6.2 | 30.8 | GO:0051673 | membrane disruption in other organism(GO:0051673) |
| 6.0 | 24.2 | GO:0052552 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
| 5.9 | 53.4 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 5.9 | 76.5 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
| 5.8 | 23.4 | GO:0002399 | MHC class II protein complex assembly(GO:0002399) |
| 5.8 | 28.8 | GO:0035995 | detection of muscle stretch(GO:0035995) |
| 5.6 | 28.0 | GO:0010903 | negative regulation of very-low-density lipoprotein particle remodeling(GO:0010903) |
| 5.6 | 22.2 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
| 5.4 | 16.3 | GO:0009397 | folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 5.3 | 31.5 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 5.1 | 25.6 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 5.1 | 30.6 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 5.0 | 20.1 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
| 5.0 | 19.9 | GO:0061107 | seminal vesicle development(GO:0061107) |
| 4.8 | 19.1 | GO:0003095 | pressure natriuresis(GO:0003095) |
| 4.7 | 14.2 | GO:0035691 | macrophage migration inhibitory factor signaling pathway(GO:0035691) |
| 4.7 | 47.2 | GO:0051126 | negative regulation of actin nucleation(GO:0051126) |
| 4.7 | 98.5 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
| 4.6 | 18.2 | GO:0002774 | Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
| 4.4 | 17.5 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
| 4.3 | 17.1 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
| 4.2 | 8.4 | GO:1903015 | regulation of exo-alpha-sialidase activity(GO:1903015) |
| 4.1 | 12.4 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
| 4.1 | 16.3 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 4.1 | 16.2 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
| 4.0 | 12.0 | GO:0061760 | antifungal innate immune response(GO:0061760) |
| 3.9 | 11.7 | GO:0002818 | intracellular defense response(GO:0002818) |
| 3.9 | 3.9 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
| 3.9 | 15.5 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 3.8 | 11.5 | GO:0034371 | chylomicron remodeling(GO:0034371) |
| 3.8 | 15.2 | GO:1903413 | cellular response to bile acid(GO:1903413) |
| 3.8 | 22.8 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
| 3.8 | 7.5 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
| 3.7 | 15.0 | GO:0035627 | ceramide transport(GO:0035627) |
| 3.6 | 14.4 | GO:0050904 | diapedesis(GO:0050904) |
| 3.6 | 14.4 | GO:0033076 | isoquinoline alkaloid metabolic process(GO:0033076) |
| 3.6 | 28.8 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
| 3.6 | 18.0 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
| 3.6 | 17.9 | GO:0090131 | mesenchyme migration(GO:0090131) |
| 3.5 | 7.1 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
| 3.5 | 10.6 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 3.5 | 7.0 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
| 3.5 | 10.5 | GO:0090675 | intermicrovillar adhesion(GO:0090675) |
| 3.5 | 3.5 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 3.4 | 10.3 | GO:0009720 | detection of hormone stimulus(GO:0009720) |
| 3.4 | 44.5 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
| 3.4 | 13.6 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
| 3.4 | 13.6 | GO:0005985 | sucrose metabolic process(GO:0005985) sucrose biosynthetic process(GO:0005986) |
| 3.3 | 3.3 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
| 3.3 | 10.0 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
| 3.3 | 16.6 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
| 3.3 | 9.9 | GO:1901162 | primary amino compound biosynthetic process(GO:1901162) |
| 3.3 | 42.3 | GO:0042167 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 3.2 | 3.2 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
| 3.2 | 12.9 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
| 3.2 | 12.8 | GO:0038124 | toll-like receptor TLR6:TLR2 signaling pathway(GO:0038124) response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
| 3.2 | 12.7 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
| 3.2 | 9.5 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
| 3.1 | 264.4 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
| 3.1 | 6.3 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
| 3.1 | 40.2 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
| 3.0 | 21.2 | GO:0002933 | lipid hydroxylation(GO:0002933) |
| 3.0 | 18.1 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
| 3.0 | 29.9 | GO:0008228 | opsonization(GO:0008228) |
| 3.0 | 11.9 | GO:1903755 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 3.0 | 11.9 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
| 3.0 | 17.7 | GO:1900004 | negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
| 2.9 | 20.5 | GO:1990822 | basic amino acid transmembrane transport(GO:1990822) |
| 2.9 | 8.8 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
| 2.9 | 8.7 | GO:0009447 | putrescine catabolic process(GO:0009447) |
| 2.9 | 8.7 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
| 2.9 | 20.1 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
| 2.9 | 8.6 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 2.8 | 31.3 | GO:0006069 | ethanol oxidation(GO:0006069) |
| 2.8 | 11.4 | GO:0002357 | defense response to tumor cell(GO:0002357) |
| 2.8 | 8.5 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
| 2.8 | 8.5 | GO:1901253 | negative regulation of intracellular transport of viral material(GO:1901253) |
| 2.8 | 5.6 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
| 2.8 | 16.7 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 2.8 | 8.4 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
| 2.8 | 8.3 | GO:0043606 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 2.8 | 8.3 | GO:0043605 | cellular amide catabolic process(GO:0043605) |
| 2.8 | 11.0 | GO:0006562 | proline catabolic process(GO:0006562) |
| 2.7 | 13.7 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
| 2.7 | 16.4 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 2.7 | 10.8 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 2.7 | 5.4 | GO:1901899 | positive regulation of relaxation of cardiac muscle(GO:1901899) |
| 2.7 | 10.7 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 2.7 | 8.0 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
| 2.7 | 21.4 | GO:0070236 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 2.6 | 50.2 | GO:0015671 | oxygen transport(GO:0015671) |
| 2.6 | 18.4 | GO:1902731 | negative regulation of chondrocyte proliferation(GO:1902731) |
| 2.6 | 18.2 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
| 2.6 | 10.3 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 2.6 | 7.7 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
| 2.6 | 10.2 | GO:0002238 | response to molecule of fungal origin(GO:0002238) cellular response to molecule of fungal origin(GO:0071226) |
| 2.5 | 12.7 | GO:1905225 | response to thyrotropin-releasing hormone(GO:1905225) |
| 2.5 | 5.0 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
| 2.5 | 15.1 | GO:0070944 | neutrophil mediated cytotoxicity(GO:0070942) neutrophil mediated killing of symbiont cell(GO:0070943) neutrophil mediated killing of bacterium(GO:0070944) |
| 2.5 | 32.7 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
| 2.5 | 10.1 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 2.5 | 7.5 | GO:0038156 | interleukin-3-mediated signaling pathway(GO:0038156) |
| 2.5 | 10.0 | GO:0009440 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 2.5 | 2.5 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
| 2.5 | 22.3 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
| 2.5 | 17.3 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
| 2.5 | 9.9 | GO:0090299 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 2.4 | 4.8 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 2.4 | 7.2 | GO:0006711 | estrogen catabolic process(GO:0006711) |
| 2.4 | 11.8 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 2.4 | 9.5 | GO:0006064 | glucuronate catabolic process(GO:0006064) glucuronate catabolic process to xylulose 5-phosphate(GO:0019640) xylulose 5-phosphate metabolic process(GO:0051167) xylulose 5-phosphate biosynthetic process(GO:1901159) |
| 2.3 | 2.3 | GO:0023021 | termination of signal transduction(GO:0023021) |
| 2.3 | 14.0 | GO:0009635 | response to herbicide(GO:0009635) |
| 2.3 | 9.3 | GO:0002034 | regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
| 2.3 | 2.3 | GO:0030961 | peptidyl-arginine hydroxylation(GO:0030961) |
| 2.3 | 9.2 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
| 2.3 | 2.3 | GO:0045136 | development of secondary sexual characteristics(GO:0045136) |
| 2.3 | 6.9 | GO:2000547 | dendritic cell dendrite assembly(GO:0097026) regulation of dendritic cell dendrite assembly(GO:2000547) |
| 2.3 | 6.9 | GO:0070846 | misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 2.3 | 9.1 | GO:0046006 | regulation of activated T cell proliferation(GO:0046006) |
| 2.3 | 9.1 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
| 2.3 | 6.8 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
| 2.3 | 6.8 | GO:0021558 | trochlear nerve development(GO:0021558) |
| 2.3 | 9.0 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
| 2.3 | 6.8 | GO:0071350 | interleukin-15-mediated signaling pathway(GO:0035723) cellular response to interleukin-15(GO:0071350) |
| 2.3 | 9.0 | GO:0036369 | transcription factor catabolic process(GO:0036369) |
| 2.3 | 6.8 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 2.2 | 4.5 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
| 2.2 | 4.5 | GO:1901523 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
| 2.2 | 6.7 | GO:1904845 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
| 2.2 | 13.3 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 2.2 | 15.5 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
| 2.2 | 2.2 | GO:1904720 | regulation of mRNA cleavage(GO:0031437) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) |
| 2.2 | 11.0 | GO:0044855 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
| 2.2 | 2.2 | GO:0021539 | subthalamus development(GO:0021539) |
| 2.2 | 4.3 | GO:0075071 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 2.2 | 6.5 | GO:0051710 | regulation of cytolysis in other organism(GO:0051710) |
| 2.2 | 6.5 | GO:0098758 | response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
| 2.1 | 2.1 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
| 2.1 | 8.5 | GO:0015911 | plasma membrane long-chain fatty acid transport(GO:0015911) |
| 2.1 | 10.5 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 2.1 | 6.3 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 2.1 | 8.3 | GO:1902528 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 2.1 | 6.2 | GO:0030221 | basophil differentiation(GO:0030221) |
| 2.1 | 4.1 | GO:0002351 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
| 2.1 | 4.1 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
| 2.0 | 14.3 | GO:1905065 | positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
| 2.0 | 24.6 | GO:0019530 | taurine metabolic process(GO:0019530) |
| 2.0 | 4.1 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 2.0 | 2.0 | GO:1901074 | regulation of engulfment of apoptotic cell(GO:1901074) |
| 2.0 | 2.0 | GO:0031959 | mineralocorticoid receptor signaling pathway(GO:0031959) |
| 2.0 | 8.1 | GO:0071231 | cellular response to folic acid(GO:0071231) |
| 2.0 | 8.1 | GO:0052053 | modulation by virus of host molecular function(GO:0039506) suppression by virus of host molecular function(GO:0039507) suppression by virus of host catalytic activity(GO:0039513) modulation by virus of host catalytic activity(GO:0039516) suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process(GO:0039650) negative regulation by symbiont of host catalytic activity(GO:0052053) negative regulation by symbiont of host molecular function(GO:0052056) modulation by symbiont of host catalytic activity(GO:0052148) |
| 2.0 | 14.1 | GO:1904100 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
| 2.0 | 6.0 | GO:0003218 | cardiac left ventricle formation(GO:0003218) |
| 2.0 | 6.0 | GO:2000417 | negative regulation of eosinophil migration(GO:2000417) |
| 2.0 | 6.0 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 2.0 | 6.0 | GO:0034370 | triglyceride-rich lipoprotein particle remodeling(GO:0034370) |
| 2.0 | 5.9 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
| 2.0 | 3.9 | GO:1902218 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) |
| 2.0 | 5.9 | GO:0098507 | polynucleotide 5' dephosphorylation(GO:0098507) |
| 2.0 | 41.3 | GO:0045730 | respiratory burst(GO:0045730) |
| 2.0 | 5.9 | GO:0061698 | protein demalonylation(GO:0036046) peptidyl-lysine demalonylation(GO:0036047) protein desuccinylation(GO:0036048) peptidyl-lysine desuccinylation(GO:0036049) protein deglutarylation(GO:0061698) peptidyl-lysine deglutarylation(GO:0061699) |
| 2.0 | 9.8 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
| 2.0 | 7.8 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
| 1.9 | 33.0 | GO:1990845 | adaptive thermogenesis(GO:1990845) |
| 1.9 | 31.0 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
| 1.9 | 27.0 | GO:0038203 | TORC2 signaling(GO:0038203) |
| 1.9 | 3.8 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
| 1.9 | 9.5 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
| 1.9 | 3.8 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
| 1.9 | 9.4 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
| 1.9 | 17.0 | GO:0072553 | terminal button organization(GO:0072553) |
| 1.9 | 5.6 | GO:0060697 | positive regulation of phospholipid catabolic process(GO:0060697) |
| 1.9 | 7.5 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
| 1.9 | 3.7 | GO:0002249 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
| 1.9 | 3.7 | GO:2001187 | positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
| 1.9 | 22.4 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
| 1.9 | 7.4 | GO:0019418 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
| 1.9 | 5.6 | GO:1990168 | protein K33-linked deubiquitination(GO:1990168) |
| 1.8 | 20.1 | GO:0006657 | CDP-choline pathway(GO:0006657) |
| 1.8 | 3.6 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
| 1.8 | 5.4 | GO:0045643 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
| 1.8 | 14.4 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 1.8 | 5.3 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
| 1.8 | 15.9 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
| 1.8 | 23.0 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
| 1.8 | 14.1 | GO:0015705 | iodide transport(GO:0015705) |
| 1.7 | 5.2 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
| 1.7 | 17.3 | GO:0001955 | blood vessel maturation(GO:0001955) |
| 1.7 | 1.7 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
| 1.7 | 1.7 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
| 1.7 | 34.2 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
| 1.7 | 15.4 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
| 1.7 | 13.7 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
| 1.7 | 1.7 | GO:0071554 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
| 1.7 | 1.7 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 1.7 | 5.1 | GO:1902948 | regulation of choline O-acetyltransferase activity(GO:1902769) positive regulation of choline O-acetyltransferase activity(GO:1902771) negative regulation of tau-protein kinase activity(GO:1902948) positive regulation of early endosome to recycling endosome transport(GO:1902955) negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902960) negative regulation of neurofibrillary tangle assembly(GO:1902997) negative regulation of aspartic-type peptidase activity(GO:1905246) |
| 1.7 | 13.6 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
| 1.7 | 13.6 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
| 1.7 | 5.1 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 1.7 | 6.7 | GO:0015669 | gas transport(GO:0015669) carbon dioxide transport(GO:0015670) |
| 1.7 | 1.7 | GO:0002159 | desmosome assembly(GO:0002159) |
| 1.7 | 5.0 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 1.7 | 8.3 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
| 1.6 | 164.6 | GO:0031295 | T cell costimulation(GO:0031295) |
| 1.6 | 6.6 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 1.6 | 4.9 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
| 1.6 | 11.5 | GO:0034587 | piRNA metabolic process(GO:0034587) |
| 1.6 | 4.9 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
| 1.6 | 24.6 | GO:0060452 | positive regulation of cardiac muscle contraction(GO:0060452) |
| 1.6 | 9.8 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
| 1.6 | 8.2 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
| 1.6 | 4.9 | GO:0070407 | oxidation-dependent protein catabolic process(GO:0070407) |
| 1.6 | 3.2 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
| 1.6 | 6.5 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
| 1.6 | 6.4 | GO:0019086 | late viral transcription(GO:0019086) |
| 1.6 | 9.6 | GO:0008218 | bioluminescence(GO:0008218) |
| 1.6 | 4.8 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
| 1.6 | 15.9 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
| 1.6 | 6.4 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
| 1.6 | 4.8 | GO:0018094 | protein polyglycylation(GO:0018094) |
| 1.6 | 9.5 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
| 1.6 | 7.9 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
| 1.6 | 4.7 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 1.6 | 45.5 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 1.6 | 4.7 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
| 1.6 | 4.7 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
| 1.6 | 6.2 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
| 1.6 | 24.9 | GO:0001976 | neurological system process involved in regulation of systemic arterial blood pressure(GO:0001976) |
| 1.6 | 4.7 | GO:1902595 | regulation of DNA replication origin binding(GO:1902595) |
| 1.5 | 4.6 | GO:1905063 | regulation of vascular smooth muscle cell differentiation(GO:1905063) |
| 1.5 | 7.7 | GO:0046618 | drug export(GO:0046618) |
| 1.5 | 9.2 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
| 1.5 | 6.1 | GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
| 1.5 | 1.5 | GO:0060214 | endocardium formation(GO:0060214) |
| 1.5 | 6.1 | GO:0048539 | bone marrow development(GO:0048539) |
| 1.5 | 18.3 | GO:2001204 | regulation of osteoclast development(GO:2001204) |
| 1.5 | 6.1 | GO:0071361 | cellular response to ethanol(GO:0071361) |
| 1.5 | 1.5 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
| 1.5 | 10.6 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
| 1.5 | 9.1 | GO:0060744 | thelarche(GO:0042695) development of secondary female sexual characteristics(GO:0046543) mammary gland branching involved in thelarche(GO:0060744) |
| 1.5 | 1.5 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
| 1.5 | 7.5 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 1.5 | 3.0 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
| 1.5 | 4.5 | GO:0019732 | antifungal humoral response(GO:0019732) |
| 1.5 | 6.0 | GO:0010193 | response to ozone(GO:0010193) |
| 1.5 | 6.0 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 1.5 | 1.5 | GO:0002339 | B cell selection(GO:0002339) |
| 1.5 | 4.4 | GO:0035900 | response to isolation stress(GO:0035900) |
| 1.5 | 4.4 | GO:0048865 | stem cell fate commitment(GO:0048865) |
| 1.5 | 4.4 | GO:0014813 | skeletal muscle satellite cell commitment(GO:0014813) |
| 1.5 | 8.8 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 1.5 | 5.8 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
| 1.5 | 4.4 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
| 1.5 | 10.2 | GO:0016139 | glycoside catabolic process(GO:0016139) |
| 1.4 | 4.3 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
| 1.4 | 8.7 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
| 1.4 | 5.8 | GO:0006568 | tryptophan metabolic process(GO:0006568) |
| 1.4 | 23.0 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 1.4 | 1.4 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
| 1.4 | 20.1 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
| 1.4 | 5.7 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) activation of phospholipase A2 activity(GO:0032431) |
| 1.4 | 2.9 | GO:0090191 | negative regulation of mesonephros development(GO:0061218) negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
| 1.4 | 5.7 | GO:1904383 | response to sodium phosphate(GO:1904383) |
| 1.4 | 10.0 | GO:0006116 | NADH oxidation(GO:0006116) |
| 1.4 | 4.3 | GO:0048633 | fermentation(GO:0006113) regulation of fermentation(GO:0043465) positive regulation of skeletal muscle tissue growth(GO:0048633) |
| 1.4 | 4.3 | GO:0035565 | regulation of pronephros size(GO:0035565) |
| 1.4 | 11.4 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 1.4 | 4.3 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
| 1.4 | 4.2 | GO:0060005 | vestibular reflex(GO:0060005) |
| 1.4 | 18.3 | GO:0071318 | cellular response to ATP(GO:0071318) |
| 1.4 | 4.2 | GO:0070625 | zymogen granule exocytosis(GO:0070625) |
| 1.4 | 4.2 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 1.4 | 9.8 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 1.4 | 11.1 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
| 1.4 | 4.2 | GO:0006683 | galactosylceramide catabolic process(GO:0006683) |
| 1.4 | 4.2 | GO:1901053 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
| 1.4 | 5.5 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
| 1.4 | 5.5 | GO:0002347 | response to tumor cell(GO:0002347) |
| 1.4 | 6.9 | GO:0032571 | response to vitamin K(GO:0032571) |
| 1.4 | 6.8 | GO:0001826 | inner cell mass cell differentiation(GO:0001826) |
| 1.4 | 12.3 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
| 1.4 | 8.2 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 1.4 | 1.4 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) |
| 1.4 | 6.8 | GO:0051552 | flavone metabolic process(GO:0051552) |
| 1.4 | 4.1 | GO:0015793 | glycerol transport(GO:0015793) |
| 1.4 | 23.0 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
| 1.3 | 2.7 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
| 1.3 | 5.4 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 1.3 | 26.9 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
| 1.3 | 8.1 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 1.3 | 2.7 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
| 1.3 | 2.7 | GO:0003343 | proepicardium development(GO:0003342) septum transversum development(GO:0003343) |
| 1.3 | 6.7 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
| 1.3 | 13.3 | GO:0070166 | enamel mineralization(GO:0070166) |
| 1.3 | 4.0 | GO:2000416 | regulation of eosinophil migration(GO:2000416) positive regulation of eosinophil migration(GO:2000418) |
| 1.3 | 8.0 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
| 1.3 | 190.2 | GO:0002377 | immunoglobulin production(GO:0002377) |
| 1.3 | 4.0 | GO:0046967 | cytosol to ER transport(GO:0046967) |
| 1.3 | 5.3 | GO:0050665 | hydrogen peroxide biosynthetic process(GO:0050665) |
| 1.3 | 9.3 | GO:0043129 | surfactant homeostasis(GO:0043129) |
| 1.3 | 5.3 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
| 1.3 | 14.5 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
| 1.3 | 2.6 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 1.3 | 23.5 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
| 1.3 | 3.9 | GO:0050798 | activated T cell proliferation(GO:0050798) |
| 1.3 | 6.5 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
| 1.3 | 6.4 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
| 1.3 | 7.7 | GO:0010734 | protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) |
| 1.3 | 1.3 | GO:0072053 | renal inner medulla development(GO:0072053) renal outer medulla development(GO:0072054) |
| 1.3 | 1.3 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
| 1.3 | 2.5 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
| 1.3 | 5.1 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
| 1.3 | 7.6 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
| 1.3 | 2.5 | GO:0044351 | macropinocytosis(GO:0044351) |
| 1.3 | 6.3 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 1.3 | 5.1 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 1.3 | 3.8 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
| 1.3 | 5.0 | GO:0060751 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) branch elongation involved in mammary gland duct branching(GO:0060751) |
| 1.3 | 1.3 | GO:1902358 | sulfate transmembrane transport(GO:1902358) |
| 1.3 | 1.3 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
| 1.2 | 2.5 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 1.2 | 1.2 | GO:0060775 | mediolateral intercalation(GO:0060031) planar cell polarity pathway involved in gastrula mediolateral intercalation(GO:0060775) |
| 1.2 | 69.2 | GO:0006953 | acute-phase response(GO:0006953) |
| 1.2 | 3.7 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) |
| 1.2 | 85.7 | GO:0032945 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
| 1.2 | 8.6 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
| 1.2 | 3.7 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
| 1.2 | 3.7 | GO:0000050 | urea cycle(GO:0000050) |
| 1.2 | 3.6 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
| 1.2 | 9.7 | GO:0030091 | protein repair(GO:0030091) |
| 1.2 | 4.8 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
| 1.2 | 2.4 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
| 1.2 | 2.4 | GO:0042414 | epinephrine metabolic process(GO:0042414) epinephrine biosynthetic process(GO:0042418) |
| 1.2 | 4.8 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
| 1.2 | 4.8 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) |
| 1.2 | 1.2 | GO:0001555 | oocyte growth(GO:0001555) |
| 1.2 | 5.9 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
| 1.2 | 1.2 | GO:0044253 | positive regulation of collagen metabolic process(GO:0010714) positive regulation of multicellular organismal metabolic process(GO:0044253) |
| 1.2 | 19.0 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
| 1.2 | 1.2 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
| 1.2 | 3.5 | GO:0050928 | negative regulation of positive chemotaxis(GO:0050928) |
| 1.2 | 1.2 | GO:0002326 | B cell lineage commitment(GO:0002326) |
| 1.2 | 5.9 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
| 1.2 | 1.2 | GO:0035106 | operant conditioning(GO:0035106) |
| 1.2 | 4.7 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
| 1.2 | 7.1 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 1.2 | 20.0 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
| 1.2 | 13.9 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 1.2 | 8.1 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
| 1.2 | 6.9 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
| 1.2 | 28.9 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 1.2 | 3.5 | GO:0010536 | regulation of activation of Janus kinase activity(GO:0010533) positive regulation of activation of Janus kinase activity(GO:0010536) |
| 1.1 | 4.5 | GO:1904954 | canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904954) |
| 1.1 | 3.4 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
| 1.1 | 6.8 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) |
| 1.1 | 4.5 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
| 1.1 | 2.3 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
| 1.1 | 7.9 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 1.1 | 5.6 | GO:0001880 | Mullerian duct regression(GO:0001880) |
| 1.1 | 10.0 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
| 1.1 | 13.3 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
| 1.1 | 1.1 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
| 1.1 | 14.4 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
| 1.1 | 3.3 | GO:0009386 | translational attenuation(GO:0009386) |
| 1.1 | 3.3 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
| 1.1 | 3.3 | GO:0046968 | peptide antigen transport(GO:0046968) |
| 1.1 | 5.5 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
| 1.1 | 6.6 | GO:0015811 | L-cystine transport(GO:0015811) |
| 1.1 | 3.3 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 1.1 | 12.1 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
| 1.1 | 11.0 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
| 1.1 | 19.7 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 1.1 | 11.9 | GO:0045008 | depyrimidination(GO:0045008) |
| 1.1 | 1.1 | GO:1903921 | protein processing in phagocytic vesicle(GO:1900756) regulation of protein processing in phagocytic vesicle(GO:1903921) positive regulation of protein processing in phagocytic vesicle(GO:1903923) |
| 1.1 | 3.2 | GO:0061011 | hepatic duct development(GO:0061011) hepatoblast differentiation(GO:0061017) |
| 1.1 | 8.6 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 1.1 | 3.2 | GO:0042361 | menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
| 1.1 | 5.3 | GO:0048541 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) Peyer's patch morphogenesis(GO:0061146) |
| 1.1 | 4.2 | GO:0032904 | viral protein processing(GO:0019082) regulation of nerve growth factor production(GO:0032903) negative regulation of nerve growth factor production(GO:0032904) dibasic protein processing(GO:0090472) |
| 1.0 | 2.1 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) |
| 1.0 | 5.2 | GO:0034201 | response to oleic acid(GO:0034201) |
| 1.0 | 5.2 | GO:0033668 | suppression by virus of host apoptotic process(GO:0019050) negative regulation by symbiont of host apoptotic process(GO:0033668) modulation by virus of host apoptotic process(GO:0039526) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
| 1.0 | 39.6 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
| 1.0 | 3.1 | GO:0014810 | positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014810) |
| 1.0 | 3.1 | GO:0015855 | pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
| 1.0 | 3.1 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
| 1.0 | 6.2 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
| 1.0 | 1.0 | GO:1903412 | response to bile acid(GO:1903412) |
| 1.0 | 14.4 | GO:0051969 | regulation of transmission of nerve impulse(GO:0051969) |
| 1.0 | 3.1 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
| 1.0 | 17.3 | GO:0051639 | actin filament network formation(GO:0051639) |
| 1.0 | 1.0 | GO:1903797 | positive regulation of inorganic anion transmembrane transport(GO:1903797) |
| 1.0 | 2.0 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
| 1.0 | 16.3 | GO:0033198 | response to ATP(GO:0033198) |
| 1.0 | 1.0 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
| 1.0 | 11.2 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
| 1.0 | 5.0 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) |
| 1.0 | 4.0 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 1.0 | 2.0 | GO:0042938 | dipeptide transport(GO:0042938) |
| 1.0 | 3.0 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
| 1.0 | 1.0 | GO:0061198 | fungiform papilla formation(GO:0061198) |
| 1.0 | 1.0 | GO:0048852 | hypophysis morphogenesis(GO:0048850) diencephalon morphogenesis(GO:0048852) |
| 1.0 | 6.0 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
| 1.0 | 5.0 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
| 1.0 | 5.9 | GO:0048241 | epinephrine transport(GO:0048241) |
| 1.0 | 4.0 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
| 1.0 | 5.9 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 1.0 | 2.9 | GO:0061536 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 1.0 | 5.9 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
| 1.0 | 1.0 | GO:0072708 | response to sorbitol(GO:0072708) |
| 1.0 | 1.9 | GO:0032849 | regulation of cellular pH reduction(GO:0032847) positive regulation of cellular pH reduction(GO:0032849) |
| 1.0 | 15.5 | GO:0051567 | histone H3-K9 methylation(GO:0051567) |
| 1.0 | 1.0 | GO:0032930 | positive regulation of superoxide anion generation(GO:0032930) |
| 1.0 | 5.8 | GO:1901727 | protein kinase D signaling(GO:0089700) positive regulation of histone deacetylase activity(GO:1901727) |
| 1.0 | 7.7 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 1.0 | 1.9 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
| 1.0 | 5.8 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
| 1.0 | 1.9 | GO:0014062 | regulation of serotonin secretion(GO:0014062) |
| 1.0 | 4.8 | GO:0071504 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
| 1.0 | 1.9 | GO:2001168 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 1.0 | 6.7 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
| 1.0 | 1.9 | GO:0002215 | defense response to nematode(GO:0002215) |
| 1.0 | 1.9 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
| 1.0 | 15.2 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 1.0 | 6.7 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
| 0.9 | 3.8 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.9 | 2.8 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.9 | 2.8 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
| 0.9 | 3.8 | GO:1903423 | positive regulation of synaptic vesicle endocytosis(GO:1900244) positive regulation of synaptic vesicle recycling(GO:1903423) |
| 0.9 | 3.8 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.9 | 2.8 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
| 0.9 | 1.9 | GO:0030225 | macrophage differentiation(GO:0030225) |
| 0.9 | 8.5 | GO:0097646 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 0.9 | 14.1 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
| 0.9 | 1.9 | GO:0090024 | negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
| 0.9 | 1.9 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
| 0.9 | 5.6 | GO:0071105 | response to interleukin-11(GO:0071105) |
| 0.9 | 8.4 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.9 | 15.9 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
| 0.9 | 25.3 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
| 0.9 | 0.9 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
| 0.9 | 22.4 | GO:0071622 | regulation of granulocyte chemotaxis(GO:0071622) |
| 0.9 | 41.0 | GO:0018149 | peptide cross-linking(GO:0018149) |
| 0.9 | 0.9 | GO:0034349 | glial cell apoptotic process(GO:0034349) |
| 0.9 | 1.9 | GO:0006522 | alanine metabolic process(GO:0006522) alanine catabolic process(GO:0006524) pyruvate family amino acid metabolic process(GO:0009078) pyruvate family amino acid catabolic process(GO:0009080) |
| 0.9 | 4.6 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
| 0.9 | 0.9 | GO:0015808 | L-alanine transport(GO:0015808) |
| 0.9 | 2.8 | GO:0045077 | negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
| 0.9 | 12.8 | GO:0045475 | locomotor rhythm(GO:0045475) |
| 0.9 | 10.1 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.9 | 4.6 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.9 | 3.6 | GO:0070370 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
| 0.9 | 5.5 | GO:2001293 | malonyl-CoA metabolic process(GO:2001293) |
| 0.9 | 2.7 | GO:0034444 | regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
| 0.9 | 5.4 | GO:0060482 | lobar bronchus development(GO:0060482) |
| 0.9 | 44.2 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 0.9 | 17.9 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.9 | 1.8 | GO:0006566 | threonine metabolic process(GO:0006566) |
| 0.9 | 17.9 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
| 0.9 | 2.7 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 0.9 | 3.6 | GO:0060022 | hard palate development(GO:0060022) |
| 0.9 | 7.1 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
| 0.9 | 1.8 | GO:0071280 | cellular response to copper ion(GO:0071280) |
| 0.9 | 3.5 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 0.9 | 5.3 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
| 0.9 | 3.5 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
| 0.9 | 6.1 | GO:0050666 | regulation of sulfur amino acid metabolic process(GO:0031335) regulation of homocysteine metabolic process(GO:0050666) |
| 0.9 | 3.5 | GO:0015747 | urate transport(GO:0015747) |
| 0.9 | 3.5 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
| 0.9 | 2.6 | GO:0072023 | thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
| 0.9 | 5.2 | GO:0006050 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
| 0.9 | 6.1 | GO:0044245 | polysaccharide digestion(GO:0044245) |
| 0.9 | 1.7 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 0.9 | 4.3 | GO:0002483 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) |
| 0.9 | 7.8 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.9 | 4.3 | GO:0071313 | cellular response to caffeine(GO:0071313) |
| 0.9 | 3.4 | GO:1902622 | regulation of neutrophil migration(GO:1902622) |
| 0.9 | 2.6 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
| 0.9 | 20.5 | GO:0015695 | organic cation transport(GO:0015695) |
| 0.9 | 1.7 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
| 0.9 | 4.3 | GO:0042420 | dopamine catabolic process(GO:0042420) |
| 0.9 | 16.2 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
| 0.8 | 1.7 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
| 0.8 | 4.2 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
| 0.8 | 2.5 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 0.8 | 5.9 | GO:0036476 | neuron death in response to hydrogen peroxide(GO:0036476) positive regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051343) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
| 0.8 | 2.5 | GO:0048014 | Tie signaling pathway(GO:0048014) |
| 0.8 | 6.7 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
| 0.8 | 1.7 | GO:0003350 | pulmonary myocardium development(GO:0003350) |
| 0.8 | 2.5 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 0.8 | 3.3 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.8 | 15.8 | GO:0030220 | platelet formation(GO:0030220) |
| 0.8 | 2.5 | GO:0060534 | trachea cartilage development(GO:0060534) |
| 0.8 | 4.2 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.8 | 0.8 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 0.8 | 4.1 | GO:0006772 | thiamine metabolic process(GO:0006772) |
| 0.8 | 3.3 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
| 0.8 | 4.9 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.8 | 0.8 | GO:1903781 | positive regulation of cardiac conduction(GO:1903781) |
| 0.8 | 2.5 | GO:2000395 | ubiquitin-dependent endocytosis(GO:0070086) regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
| 0.8 | 14.7 | GO:0042572 | retinol metabolic process(GO:0042572) |
| 0.8 | 7.3 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.8 | 1.6 | GO:0006059 | hexitol metabolic process(GO:0006059) |
| 0.8 | 1.6 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
| 0.8 | 9.7 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
| 0.8 | 1.6 | GO:1900365 | positive regulation of mRNA polyadenylation(GO:1900365) |
| 0.8 | 2.4 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
| 0.8 | 4.8 | GO:1903350 | response to dopamine(GO:1903350) cellular response to dopamine(GO:1903351) |
| 0.8 | 2.4 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.8 | 8.0 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 0.8 | 0.8 | GO:0070673 | response to interleukin-18(GO:0070673) |
| 0.8 | 4.0 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.8 | 12.8 | GO:0051450 | myoblast proliferation(GO:0051450) |
| 0.8 | 1.6 | GO:0014016 | neuroblast differentiation(GO:0014016) |
| 0.8 | 7.2 | GO:0035897 | proteolysis in other organism(GO:0035897) |
| 0.8 | 4.0 | GO:0071321 | cellular response to cGMP(GO:0071321) |
| 0.8 | 2.4 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
| 0.8 | 3.1 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
| 0.8 | 18.0 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.8 | 1.6 | GO:0070269 | pyroptosis(GO:0070269) |
| 0.8 | 1.6 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
| 0.8 | 3.1 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
| 0.8 | 3.1 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
| 0.8 | 3.9 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
| 0.8 | 1.5 | GO:0001554 | luteolysis(GO:0001554) |
| 0.8 | 2.3 | GO:1904397 | negative regulation of neuromuscular junction development(GO:1904397) |
| 0.8 | 3.1 | GO:0019474 | L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
| 0.8 | 3.8 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.8 | 0.8 | GO:0045362 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
| 0.8 | 5.3 | GO:0045023 | G0 to G1 transition(GO:0045023) |
| 0.8 | 0.8 | GO:0032620 | interleukin-17 production(GO:0032620) |
| 0.8 | 6.8 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
| 0.8 | 166.1 | GO:0002250 | adaptive immune response(GO:0002250) |
| 0.8 | 7.5 | GO:0007028 | cytoplasm organization(GO:0007028) |
| 0.7 | 2.2 | GO:0001842 | neural fold formation(GO:0001842) |
| 0.7 | 6.0 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
| 0.7 | 4.4 | GO:0070560 | protein secretion by platelet(GO:0070560) |
| 0.7 | 3.7 | GO:1901090 | regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
| 0.7 | 3.0 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
| 0.7 | 14.0 | GO:1901663 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.7 | 2.2 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 0.7 | 11.0 | GO:0019835 | cytolysis(GO:0019835) |
| 0.7 | 2.2 | GO:0071529 | cementum mineralization(GO:0071529) |
| 0.7 | 13.8 | GO:0015879 | carnitine transport(GO:0015879) |
| 0.7 | 0.7 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
| 0.7 | 3.6 | GO:0030070 | insulin processing(GO:0030070) |
| 0.7 | 5.8 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 0.7 | 2.2 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
| 0.7 | 2.9 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 0.7 | 5.8 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.7 | 0.7 | GO:1903960 | negative regulation of anion transmembrane transport(GO:1903960) |
| 0.7 | 2.1 | GO:0046219 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) indole-containing compound biosynthetic process(GO:0042435) indolalkylamine biosynthetic process(GO:0046219) |
| 0.7 | 0.7 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.7 | 18.4 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
| 0.7 | 0.7 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
| 0.7 | 19.8 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
| 0.7 | 2.1 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 0.7 | 4.2 | GO:0035524 | proline transmembrane transport(GO:0035524) |
| 0.7 | 9.1 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
| 0.7 | 7.0 | GO:0018377 | protein myristoylation(GO:0018377) |
| 0.7 | 3.5 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
| 0.7 | 7.7 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
| 0.7 | 0.7 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
| 0.7 | 4.9 | GO:0086068 | Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
| 0.7 | 2.8 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
| 0.7 | 2.8 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 0.7 | 2.1 | GO:0034553 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.7 | 1.4 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.7 | 2.0 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
| 0.7 | 1.4 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
| 0.7 | 0.7 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
| 0.7 | 4.7 | GO:0015886 | heme transport(GO:0015886) |
| 0.7 | 6.7 | GO:0097186 | amelogenesis(GO:0097186) |
| 0.7 | 4.0 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
| 0.7 | 0.7 | GO:0048769 | sarcomerogenesis(GO:0048769) |
| 0.7 | 1.3 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
| 0.7 | 3.4 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.7 | 4.0 | GO:0015827 | tryptophan transport(GO:0015827) |
| 0.7 | 0.7 | GO:0036343 | psychomotor behavior(GO:0036343) |
| 0.7 | 3.3 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.7 | 6.0 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
| 0.7 | 9.3 | GO:0050427 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.7 | 12.5 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
| 0.7 | 0.7 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
| 0.7 | 1.3 | GO:0072014 | proximal tubule development(GO:0072014) |
| 0.7 | 5.9 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 0.6 | 5.2 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
| 0.6 | 3.2 | GO:0038170 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.6 | 1.9 | GO:0034505 | tooth mineralization(GO:0034505) |
| 0.6 | 33.0 | GO:0006968 | cellular defense response(GO:0006968) |
| 0.6 | 3.2 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
| 0.6 | 2.5 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
| 0.6 | 3.1 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
| 0.6 | 8.2 | GO:0015884 | folic acid transport(GO:0015884) |
| 0.6 | 1.9 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
| 0.6 | 1.9 | GO:0060017 | parathyroid gland development(GO:0060017) |
| 0.6 | 3.1 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
| 0.6 | 3.7 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
| 0.6 | 0.6 | GO:0019323 | pentose catabolic process(GO:0019323) |
| 0.6 | 4.3 | GO:0006828 | manganese ion transport(GO:0006828) |
| 0.6 | 1.8 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.6 | 6.1 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
| 0.6 | 9.8 | GO:0019731 | antibacterial humoral response(GO:0019731) |
| 0.6 | 8.0 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.6 | 4.3 | GO:0006013 | mannose metabolic process(GO:0006013) |
| 0.6 | 1.2 | GO:0033123 | positive regulation of purine nucleotide catabolic process(GO:0033123) |
| 0.6 | 2.4 | GO:0009305 | protein biotinylation(GO:0009305) response to biotin(GO:0070781) histone biotinylation(GO:0071110) |
| 0.6 | 3.0 | GO:0072108 | positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0072108) |
| 0.6 | 4.8 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.6 | 9.1 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.6 | 2.4 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
| 0.6 | 1.8 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.6 | 3.0 | GO:0021886 | hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
| 0.6 | 2.4 | GO:0060591 | chondroblast differentiation(GO:0060591) |
| 0.6 | 2.4 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
| 0.6 | 2.4 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
| 0.6 | 3.6 | GO:1903232 | melanosome assembly(GO:1903232) |
| 0.6 | 5.4 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
| 0.6 | 1.2 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
| 0.6 | 1.2 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
| 0.6 | 5.9 | GO:0036065 | fucosylation(GO:0036065) |
| 0.6 | 11.7 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
| 0.6 | 2.3 | GO:0021615 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
| 0.6 | 4.0 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
| 0.6 | 9.2 | GO:1902884 | positive regulation of response to oxidative stress(GO:1902884) |
| 0.6 | 2.9 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
| 0.6 | 2.9 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.6 | 4.6 | GO:1904779 | regulation of protein localization to centrosome(GO:1904779) |
| 0.6 | 21.8 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
| 0.6 | 1.7 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
| 0.6 | 0.6 | GO:1903487 | regulation of lactation(GO:1903487) |
| 0.6 | 10.8 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
| 0.6 | 1.7 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
| 0.6 | 5.7 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
| 0.6 | 1.1 | GO:1904529 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 0.6 | 1.7 | GO:0018343 | protein prenylation(GO:0018342) protein farnesylation(GO:0018343) prenylation(GO:0097354) |
| 0.6 | 0.6 | GO:0019858 | cytosine metabolic process(GO:0019858) |
| 0.6 | 3.9 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
| 0.6 | 0.6 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
| 0.6 | 1.7 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
| 0.6 | 6.1 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
| 0.6 | 1.7 | GO:0071918 | urea transmembrane transport(GO:0071918) |
| 0.6 | 0.6 | GO:0060920 | atrioventricular node development(GO:0003162) cardiac pacemaker cell differentiation(GO:0060920) cardiac pacemaker cell development(GO:0060926) |
| 0.6 | 2.2 | GO:0097167 | circadian regulation of translation(GO:0097167) |
| 0.6 | 3.9 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
| 0.6 | 2.2 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
| 0.5 | 5.5 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
| 0.5 | 4.9 | GO:0032790 | ribosome disassembly(GO:0032790) |
| 0.5 | 3.3 | GO:0009074 | aromatic amino acid family catabolic process(GO:0009074) |
| 0.5 | 6.6 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
| 0.5 | 3.8 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
| 0.5 | 1.6 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.5 | 1.1 | GO:0002767 | immune response-inhibiting signal transduction(GO:0002765) immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
| 0.5 | 2.7 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.5 | 1.6 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
| 0.5 | 1.6 | GO:0050913 | sensory perception of bitter taste(GO:0050913) |
| 0.5 | 2.1 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
| 0.5 | 3.7 | GO:0009642 | response to light intensity(GO:0009642) |
| 0.5 | 0.5 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
| 0.5 | 2.1 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
| 0.5 | 7.4 | GO:0042116 | macrophage activation(GO:0042116) |
| 0.5 | 1.6 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.5 | 6.3 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.5 | 1.0 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
| 0.5 | 1.6 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 0.5 | 3.1 | GO:0001865 | NK T cell differentiation(GO:0001865) |
| 0.5 | 2.1 | GO:0006265 | DNA topological change(GO:0006265) |
| 0.5 | 1.0 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
| 0.5 | 0.5 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
| 0.5 | 2.6 | GO:0006489 | dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
| 0.5 | 3.6 | GO:0036010 | protein localization to endosome(GO:0036010) |
| 0.5 | 2.5 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.5 | 3.0 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) |
| 0.5 | 4.6 | GO:0040016 | embryonic cleavage(GO:0040016) |
| 0.5 | 4.1 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
| 0.5 | 1.0 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
| 0.5 | 5.0 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
| 0.5 | 10.1 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
| 0.5 | 1.5 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.5 | 1.5 | GO:0051923 | sulfation(GO:0051923) |
| 0.5 | 4.0 | GO:0044804 | nucleophagy(GO:0044804) |
| 0.5 | 1.5 | GO:0001545 | primary ovarian follicle growth(GO:0001545) |
| 0.5 | 4.4 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
| 0.5 | 3.4 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
| 0.5 | 1.0 | GO:0072244 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
| 0.5 | 1.5 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.5 | 1.0 | GO:0001757 | somite specification(GO:0001757) |
| 0.5 | 6.8 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
| 0.5 | 1.0 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
| 0.5 | 1.0 | GO:0008078 | mesodermal cell migration(GO:0008078) mesendoderm development(GO:0048382) corticotropin hormone secreting cell differentiation(GO:0060128) thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
| 0.5 | 1.4 | GO:0032759 | TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) |
| 0.5 | 2.4 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
| 0.5 | 1.4 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
| 0.5 | 0.5 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
| 0.5 | 4.8 | GO:0006692 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
| 0.5 | 2.9 | GO:0021633 | optic nerve structural organization(GO:0021633) |
| 0.5 | 7.1 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
| 0.5 | 0.9 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
| 0.5 | 0.9 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.5 | 0.9 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.5 | 4.2 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 0.5 | 0.5 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
| 0.5 | 1.4 | GO:0030812 | negative regulation of nucleotide catabolic process(GO:0030812) negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
| 0.5 | 1.4 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.5 | 1.9 | GO:0031652 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) regulation of heat generation(GO:0031650) positive regulation of heat generation(GO:0031652) negative regulation of dopamine secretion(GO:0033602) aspartate secretion(GO:0061528) positive regulation of prolactin secretion(GO:1902722) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
| 0.5 | 4.2 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
| 0.5 | 4.2 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 0.5 | 2.8 | GO:0006196 | AMP catabolic process(GO:0006196) |
| 0.5 | 2.8 | GO:0050893 | sensory processing(GO:0050893) |
| 0.5 | 0.5 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
| 0.5 | 0.9 | GO:0060319 | primitive erythrocyte differentiation(GO:0060319) |
| 0.5 | 1.8 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
| 0.5 | 5.9 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
| 0.5 | 4.5 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
| 0.5 | 0.5 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
| 0.5 | 2.7 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
| 0.5 | 1.4 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.5 | 10.9 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
| 0.5 | 1.8 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
| 0.5 | 4.5 | GO:1901642 | nucleoside transmembrane transport(GO:1901642) |
| 0.4 | 12.6 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
| 0.4 | 2.2 | GO:0048793 | pronephros development(GO:0048793) |
| 0.4 | 3.1 | GO:0002407 | dendritic cell chemotaxis(GO:0002407) |
| 0.4 | 3.6 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
| 0.4 | 6.7 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 0.4 | 1.8 | GO:0032455 | nerve growth factor processing(GO:0032455) |
| 0.4 | 21.3 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) |
| 0.4 | 2.6 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
| 0.4 | 2.6 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
| 0.4 | 3.9 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
| 0.4 | 2.6 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
| 0.4 | 6.1 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
| 0.4 | 8.6 | GO:0097320 | membrane tubulation(GO:0097320) |
| 0.4 | 2.6 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.4 | 1.7 | GO:0098957 | anterograde axonal transport of mitochondrion(GO:0098957) |
| 0.4 | 0.4 | GO:1902896 | terminal web assembly(GO:1902896) |
| 0.4 | 0.9 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
| 0.4 | 2.1 | GO:0002544 | chronic inflammatory response(GO:0002544) |
| 0.4 | 0.4 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.4 | 2.5 | GO:0002115 | store-operated calcium entry(GO:0002115) |
| 0.4 | 4.2 | GO:0016576 | histone dephosphorylation(GO:0016576) |
| 0.4 | 1.3 | GO:0046603 | negative regulation of mitotic centrosome separation(GO:0046603) |
| 0.4 | 1.3 | GO:0016240 | autophagosome docking(GO:0016240) |
| 0.4 | 3.8 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
| 0.4 | 1.2 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
| 0.4 | 14.8 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
| 0.4 | 1.2 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
| 0.4 | 1.6 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) positive regulation of protein deubiquitination(GO:1903003) |
| 0.4 | 7.8 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.4 | 2.4 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
| 0.4 | 1.2 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
| 0.4 | 2.4 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
| 0.4 | 4.4 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
| 0.4 | 5.7 | GO:0051904 | pigment granule transport(GO:0051904) |
| 0.4 | 0.8 | GO:0001912 | positive regulation of leukocyte mediated cytotoxicity(GO:0001912) |
| 0.4 | 1.2 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.4 | 24.8 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
| 0.4 | 4.4 | GO:0006590 | thyroid hormone generation(GO:0006590) |
| 0.4 | 0.8 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
| 0.4 | 4.0 | GO:0098915 | membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
| 0.4 | 0.4 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.4 | 6.4 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
| 0.4 | 2.0 | GO:0090009 | primitive streak formation(GO:0090009) |
| 0.4 | 7.1 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
| 0.4 | 3.1 | GO:0001502 | cartilage condensation(GO:0001502) |
| 0.4 | 1.2 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.4 | 2.7 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.4 | 14.7 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
| 0.4 | 1.5 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
| 0.4 | 2.3 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
| 0.4 | 3.1 | GO:0048484 | enteric nervous system development(GO:0048484) |
| 0.4 | 1.1 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
| 0.4 | 5.0 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
| 0.4 | 1.5 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
| 0.4 | 0.4 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
| 0.4 | 0.8 | GO:0007320 | insemination(GO:0007320) |
| 0.4 | 4.9 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.4 | 0.4 | GO:2000777 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
| 0.4 | 5.2 | GO:0001569 | patterning of blood vessels(GO:0001569) |
| 0.4 | 0.7 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.4 | 1.9 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
| 0.4 | 1.9 | GO:0010626 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
| 0.4 | 5.2 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
| 0.4 | 6.3 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
| 0.4 | 1.1 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
| 0.4 | 11.7 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
| 0.4 | 1.1 | GO:0010818 | T cell chemotaxis(GO:0010818) |
| 0.4 | 1.5 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.4 | 0.4 | GO:0009441 | glycolate metabolic process(GO:0009441) |
| 0.4 | 0.4 | GO:0044805 | late nucleophagy(GO:0044805) |
| 0.4 | 1.8 | GO:0043589 | skin morphogenesis(GO:0043589) |
| 0.4 | 0.7 | GO:0040030 | regulation of molecular function, epigenetic(GO:0040030) |
| 0.4 | 1.4 | GO:0030167 | proteoglycan catabolic process(GO:0030167) heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.4 | 2.8 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
| 0.4 | 1.8 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
| 0.4 | 0.4 | GO:0046684 | response to pyrethroid(GO:0046684) |
| 0.4 | 1.4 | GO:0072710 | response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) |
| 0.4 | 0.7 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
| 0.4 | 1.1 | GO:0071139 | resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
| 0.4 | 1.4 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
| 0.3 | 1.4 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
| 0.3 | 6.6 | GO:0045332 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
| 0.3 | 2.1 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
| 0.3 | 2.1 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
| 0.3 | 5.9 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
| 0.3 | 1.0 | GO:0060174 | limb bud formation(GO:0060174) |
| 0.3 | 2.8 | GO:1901475 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
| 0.3 | 1.0 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
| 0.3 | 1.0 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
| 0.3 | 2.4 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
| 0.3 | 2.0 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 0.3 | 0.7 | GO:0060939 | cardiac fibroblast cell differentiation(GO:0060935) cardiac fibroblast cell development(GO:0060936) epicardium-derived cardiac fibroblast cell differentiation(GO:0060938) epicardium-derived cardiac fibroblast cell development(GO:0060939) epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
| 0.3 | 3.4 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
| 0.3 | 1.7 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
| 0.3 | 1.0 | GO:0006565 | L-serine catabolic process(GO:0006565) |
| 0.3 | 0.3 | GO:0051182 | coenzyme transport(GO:0051182) |
| 0.3 | 1.3 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.3 | 1.3 | GO:0030259 | lipid glycosylation(GO:0030259) |
| 0.3 | 1.0 | GO:0048263 | determination of dorsal identity(GO:0048263) |
| 0.3 | 1.6 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
| 0.3 | 1.6 | GO:0030207 | chondroitin sulfate catabolic process(GO:0030207) |
| 0.3 | 0.6 | GO:0048496 | maintenance of organ identity(GO:0048496) |
| 0.3 | 2.6 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
| 0.3 | 5.8 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
| 0.3 | 3.5 | GO:0015874 | norepinephrine transport(GO:0015874) |
| 0.3 | 1.3 | GO:0016264 | gap junction assembly(GO:0016264) |
| 0.3 | 1.9 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
| 0.3 | 1.0 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
| 0.3 | 0.6 | GO:0045897 | positive regulation of transcription during mitosis(GO:0045897) |
| 0.3 | 1.0 | GO:0006538 | glutamate catabolic process(GO:0006538) |
| 0.3 | 1.3 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.3 | 1.6 | GO:0010813 | neuropeptide catabolic process(GO:0010813) |
| 0.3 | 0.6 | GO:0071104 | response to interleukin-9(GO:0071104) |
| 0.3 | 0.9 | GO:0001692 | histamine metabolic process(GO:0001692) |
| 0.3 | 0.9 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.3 | 0.9 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
| 0.3 | 2.8 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
| 0.3 | 0.6 | GO:0060037 | pharyngeal system development(GO:0060037) |
| 0.3 | 6.1 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
| 0.3 | 0.6 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
| 0.3 | 0.9 | GO:0005999 | xylulose metabolic process(GO:0005997) xylulose biosynthetic process(GO:0005999) |
| 0.3 | 4.5 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.3 | 24.6 | GO:0070268 | cornification(GO:0070268) |
| 0.3 | 0.6 | GO:0007525 | somatic muscle development(GO:0007525) |
| 0.3 | 0.6 | GO:1904569 | regulation of selenocysteine incorporation(GO:1904569) |
| 0.3 | 0.6 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.3 | 1.7 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
| 0.3 | 0.6 | GO:0032328 | alanine transport(GO:0032328) |
| 0.3 | 3.8 | GO:0060603 | mammary gland duct morphogenesis(GO:0060603) |
| 0.3 | 1.2 | GO:0033306 | phytol metabolic process(GO:0033306) fatty alcohol metabolic process(GO:1903173) |
| 0.3 | 0.6 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.3 | 0.6 | GO:0072719 | cellular response to cisplatin(GO:0072719) |
| 0.3 | 0.6 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
| 0.3 | 6.4 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.3 | 2.5 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
| 0.3 | 1.4 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
| 0.3 | 2.8 | GO:0006525 | arginine metabolic process(GO:0006525) |
| 0.3 | 1.7 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
| 0.3 | 0.8 | GO:0036233 | glycine import(GO:0036233) |
| 0.3 | 4.1 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
| 0.3 | 3.0 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
| 0.3 | 1.1 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 0.3 | 4.3 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
| 0.3 | 1.1 | GO:0051037 | regulation of transcription involved in meiotic cell cycle(GO:0051037) |
| 0.3 | 2.1 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
| 0.3 | 1.3 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
| 0.3 | 6.9 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.3 | 0.3 | GO:0044026 | DNA hypermethylation(GO:0044026) |
| 0.3 | 0.8 | GO:0045346 | regulation of MHC class II biosynthetic process(GO:0045346) |
| 0.3 | 0.8 | GO:0035864 | response to potassium ion(GO:0035864) |
| 0.3 | 1.3 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 0.3 | 2.6 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
| 0.3 | 0.3 | GO:0030862 | positive regulation of polarized epithelial cell differentiation(GO:0030862) |
| 0.3 | 1.8 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
| 0.3 | 1.5 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.3 | 2.5 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.2 | 3.2 | GO:0038092 | nodal signaling pathway(GO:0038092) |
| 0.2 | 4.5 | GO:1901687 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.2 | 1.0 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 0.2 | 1.5 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) negative regulation of tooth mineralization(GO:0070171) |
| 0.2 | 1.7 | GO:1902856 | negative regulation of nonmotile primary cilium assembly(GO:1902856) |
| 0.2 | 0.2 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.2 | 2.7 | GO:0006491 | N-glycan processing(GO:0006491) |
| 0.2 | 4.9 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
| 0.2 | 2.4 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
| 0.2 | 0.7 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
| 0.2 | 0.2 | GO:0060086 | circadian temperature homeostasis(GO:0060086) |
| 0.2 | 1.9 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
| 0.2 | 1.2 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
| 0.2 | 3.5 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
| 0.2 | 1.4 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.2 | 2.1 | GO:0007512 | adult heart development(GO:0007512) |
| 0.2 | 1.9 | GO:0046459 | short-chain fatty acid metabolic process(GO:0046459) |
| 0.2 | 0.7 | GO:1990910 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) response to hypobaric hypoxia(GO:1990910) |
| 0.2 | 1.9 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
| 0.2 | 2.3 | GO:0030238 | male sex determination(GO:0030238) |
| 0.2 | 5.3 | GO:0071420 | cellular response to histamine(GO:0071420) |
| 0.2 | 1.6 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
| 0.2 | 2.3 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 0.2 | 1.8 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
| 0.2 | 8.4 | GO:0006306 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
| 0.2 | 0.7 | GO:0099563 | modification of synaptic structure(GO:0099563) |
| 0.2 | 2.4 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.2 | 1.3 | GO:0098703 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 0.2 | 0.7 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
| 0.2 | 0.4 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.2 | 5.2 | GO:0090311 | regulation of protein deacetylation(GO:0090311) |
| 0.2 | 1.1 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
| 0.2 | 0.4 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
| 0.2 | 4.7 | GO:0042133 | neurotransmitter metabolic process(GO:0042133) |
| 0.2 | 0.2 | GO:0045649 | regulation of macrophage differentiation(GO:0045649) |
| 0.2 | 0.9 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
| 0.2 | 0.8 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.2 | 0.8 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
| 0.2 | 2.3 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
| 0.2 | 0.4 | GO:0042441 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
| 0.2 | 1.0 | GO:1904030 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
| 0.2 | 1.0 | GO:0019400 | alditol metabolic process(GO:0019400) |
| 0.2 | 2.6 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
| 0.2 | 0.8 | GO:0051194 | positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
| 0.2 | 5.8 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
| 0.2 | 0.8 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 0.2 | 1.0 | GO:0015693 | magnesium ion transport(GO:0015693) |
| 0.2 | 0.8 | GO:0045620 | negative regulation of lymphocyte differentiation(GO:0045620) |
| 0.2 | 11.4 | GO:0030574 | collagen catabolic process(GO:0030574) |
| 0.2 | 0.6 | GO:0036245 | cellular response to menadione(GO:0036245) |
| 0.2 | 2.7 | GO:0031640 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
| 0.2 | 4.2 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
| 0.2 | 0.6 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 0.2 | 1.3 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
| 0.2 | 1.5 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
| 0.2 | 7.1 | GO:0019228 | neuronal action potential(GO:0019228) |
| 0.2 | 2.0 | GO:0032570 | response to progesterone(GO:0032570) |
| 0.2 | 1.1 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
| 0.2 | 24.6 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.2 | 1.7 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
| 0.2 | 0.7 | GO:0090260 | negative regulation of retinal ganglion cell axon guidance(GO:0090260) |
| 0.2 | 0.7 | GO:2001240 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
| 0.2 | 1.6 | GO:0014029 | neural crest formation(GO:0014029) |
| 0.2 | 0.4 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
| 0.2 | 2.3 | GO:0050881 | multicellular organismal movement(GO:0050879) musculoskeletal movement(GO:0050881) |
| 0.2 | 0.7 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.2 | 1.1 | GO:0046092 | deoxycytidine metabolic process(GO:0046092) |
| 0.2 | 1.4 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.2 | 1.7 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
| 0.2 | 0.9 | GO:0090520 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.2 | 1.0 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
| 0.2 | 0.2 | GO:0042737 | drug catabolic process(GO:0042737) |
| 0.2 | 1.0 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.2 | 0.3 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
| 0.2 | 1.2 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
| 0.2 | 1.5 | GO:0007618 | mating(GO:0007618) |
| 0.2 | 1.8 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.2 | 1.2 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
| 0.2 | 0.7 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.2 | 6.7 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
| 0.2 | 0.7 | GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway(GO:0031664) |
| 0.2 | 2.0 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
| 0.2 | 1.6 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
| 0.2 | 0.3 | GO:0080184 | response to stilbenoid(GO:0035634) response to phenylpropanoid(GO:0080184) |
| 0.2 | 0.6 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
| 0.1 | 0.6 | GO:0006768 | biotin metabolic process(GO:0006768) |
| 0.1 | 1.3 | GO:0010225 | response to UV-C(GO:0010225) |
| 0.1 | 2.3 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
| 0.1 | 0.1 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
| 0.1 | 0.7 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
| 0.1 | 1.8 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.1 | 0.6 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
| 0.1 | 1.7 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
| 0.1 | 1.4 | GO:1903020 | positive regulation of glycoprotein metabolic process(GO:1903020) |
| 0.1 | 1.0 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
| 0.1 | 0.4 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.1 | 0.5 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.1 | 0.1 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
| 0.1 | 0.5 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
| 0.1 | 0.4 | GO:0046415 | urate metabolic process(GO:0046415) |
| 0.1 | 0.8 | GO:0006543 | glutamine catabolic process(GO:0006543) |
| 0.1 | 0.8 | GO:2000398 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
| 0.1 | 0.5 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 0.1 | 0.1 | GO:0010511 | regulation of phosphatidylinositol biosynthetic process(GO:0010511) positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
| 0.1 | 0.4 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.1 | 6.3 | GO:0051865 | protein autoubiquitination(GO:0051865) |
| 0.1 | 0.4 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
| 0.1 | 0.4 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
| 0.1 | 1.4 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) |
| 0.1 | 0.7 | GO:0098909 | regulation of cardiac muscle cell action potential involved in regulation of contraction(GO:0098909) |
| 0.1 | 0.6 | GO:0001709 | cell fate determination(GO:0001709) |
| 0.1 | 1.0 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
| 0.1 | 0.2 | GO:0042723 | thiamine-containing compound metabolic process(GO:0042723) |
| 0.1 | 1.2 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.1 | 0.3 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.1 | 0.6 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) positive regulation of autophagosome maturation(GO:1901098) |
| 0.1 | 0.2 | GO:0098743 | cell aggregation(GO:0098743) |
| 0.1 | 0.5 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
| 0.1 | 0.3 | GO:0030916 | otic vesicle formation(GO:0030916) |
| 0.1 | 1.2 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
| 0.1 | 3.3 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
| 0.1 | 0.6 | GO:0048483 | autonomic nervous system development(GO:0048483) |
| 0.1 | 1.9 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
| 0.1 | 0.9 | GO:0003351 | epithelial cilium movement(GO:0003351) |
| 0.1 | 0.3 | GO:1901160 | indole-containing compound metabolic process(GO:0042430) primary amino compound metabolic process(GO:1901160) |
| 0.1 | 0.4 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
| 0.1 | 1.1 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
| 0.1 | 1.0 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
| 0.1 | 1.7 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
| 0.1 | 0.4 | GO:0033197 | response to vitamin E(GO:0033197) |
| 0.1 | 1.2 | GO:0031424 | keratinization(GO:0031424) |
| 0.1 | 0.7 | GO:0006544 | glycine metabolic process(GO:0006544) |
| 0.1 | 0.8 | GO:0099515 | vesicle transport along actin filament(GO:0030050) actin filament-based transport(GO:0099515) |
| 0.1 | 1.1 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.1 | 1.7 | GO:0031648 | protein destabilization(GO:0031648) |
| 0.1 | 0.5 | GO:0042993 | positive regulation of transcription factor import into nucleus(GO:0042993) |
| 0.1 | 0.8 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
| 0.1 | 0.3 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
| 0.1 | 0.2 | GO:0070633 | transepithelial transport(GO:0070633) |
| 0.1 | 0.6 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
| 0.1 | 0.1 | GO:0036005 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
| 0.1 | 2.0 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
| 0.1 | 0.3 | GO:0014894 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.1 | 0.8 | GO:0032098 | regulation of appetite(GO:0032098) |
| 0.1 | 0.2 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
| 0.1 | 0.7 | GO:0070828 | heterochromatin organization(GO:0070828) |
| 0.1 | 0.1 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
| 0.1 | 2.0 | GO:0006198 | cAMP catabolic process(GO:0006198) |
| 0.1 | 1.9 | GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
| 0.1 | 0.9 | GO:0032649 | regulation of interferon-gamma production(GO:0032649) |
| 0.1 | 0.1 | GO:0021779 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
| 0.1 | 0.5 | GO:0060285 | cilium-dependent cell motility(GO:0060285) |
| 0.1 | 0.1 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
| 0.1 | 1.6 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
| 0.1 | 0.4 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
| 0.1 | 0.1 | GO:0032095 | regulation of response to food(GO:0032095) |
| 0.1 | 0.2 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.1 | 0.3 | GO:0035902 | response to immobilization stress(GO:0035902) |
| 0.1 | 0.3 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
| 0.1 | 0.3 | GO:0006063 | uronic acid metabolic process(GO:0006063) glucuronate metabolic process(GO:0019585) |
| 0.0 | 0.3 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
| 0.0 | 0.1 | GO:1903464 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) regulation of mitotic cell cycle DNA replication(GO:1903463) negative regulation of mitotic cell cycle DNA replication(GO:1903464) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
| 0.0 | 0.2 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.0 | 0.0 | GO:0042304 | regulation of fatty acid biosynthetic process(GO:0042304) |
| 0.0 | 0.1 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
| 0.0 | 0.5 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.0 | 0.9 | GO:0071621 | granulocyte chemotaxis(GO:0071621) |
| 0.0 | 0.5 | GO:0021988 | olfactory lobe development(GO:0021988) |
| 0.0 | 0.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.0 | 0.1 | GO:0098935 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
| 0.0 | 0.3 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
| 0.0 | 0.3 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
| 0.0 | 0.1 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
| 0.0 | 0.9 | GO:0030217 | T cell differentiation(GO:0030217) |
| 0.0 | 0.1 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
| 0.0 | 0.0 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
| 0.0 | 0.2 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.0 | 1.1 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.0 | 0.2 | GO:1904894 | positive regulation of JAK-STAT cascade(GO:0046427) positive regulation of STAT cascade(GO:1904894) |
| 0.0 | 0.1 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
| 0.0 | 0.2 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 0.0 | 0.0 | GO:1901877 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
| 0.0 | 0.0 | GO:1905053 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 0.0 | 0.5 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) |
| 0.0 | 0.2 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.0 | 1.2 | GO:0042384 | cilium assembly(GO:0042384) |
| 0.0 | 0.1 | GO:0006907 | pinocytosis(GO:0006907) |
| 0.0 | 0.2 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
| 0.0 | 0.1 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 0.0 | 0.1 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
| 0.0 | 0.1 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
| 0.0 | 0.3 | GO:0016266 | O-glycan processing(GO:0016266) |
| 0.0 | 0.1 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
| 0.0 | 0.4 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
Gene overrepresentation in cellular component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 32.4 | 97.1 | GO:0071750 | dimeric IgA immunoglobulin complex(GO:0071750) secretory dimeric IgA immunoglobulin complex(GO:0071752) |
| 24.3 | 48.6 | GO:0071756 | IgM immunoglobulin complex(GO:0071753) IgM immunoglobulin complex, circulating(GO:0071754) pentameric IgM immunoglobulin complex(GO:0071756) |
| 13.3 | 637.4 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
| 9.1 | 173.6 | GO:0042613 | MHC class II protein complex(GO:0042613) |
| 8.3 | 25.0 | GO:0097180 | protein C inhibitor-TMPRSS7 complex(GO:0036024) protein C inhibitor-TMPRSS11E complex(GO:0036025) protein C inhibitor-PLAT complex(GO:0036026) protein C inhibitor-PLAU complex(GO:0036027) protein C inhibitor-thrombin complex(GO:0036028) protein C inhibitor-KLK3 complex(GO:0036029) protein C inhibitor-plasma kallikrein complex(GO:0036030) serine protease inhibitor complex(GO:0097180) protein C inhibitor-coagulation factor V complex(GO:0097181) protein C inhibitor-coagulation factor Xa complex(GO:0097182) protein C inhibitor-coagulation factor XI complex(GO:0097183) |
| 7.4 | 44.3 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
| 6.8 | 40.8 | GO:0005927 | muscle tendon junction(GO:0005927) |
| 6.1 | 30.7 | GO:0001652 | granular component(GO:0001652) |
| 6.0 | 41.8 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
| 4.9 | 54.4 | GO:0042611 | MHC protein complex(GO:0042611) |
| 4.9 | 29.2 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
| 4.4 | 48.3 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
| 4.0 | 16.1 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
| 3.8 | 34.1 | GO:0032010 | phagolysosome(GO:0032010) |
| 3.7 | 14.8 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
| 3.5 | 7.0 | GO:0005602 | complement component C1 complex(GO:0005602) |
| 3.5 | 31.4 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
| 3.3 | 3.3 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
| 3.3 | 19.6 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
| 3.2 | 19.5 | GO:0044194 | cytolytic granule(GO:0044194) |
| 3.2 | 25.7 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
| 3.2 | 12.6 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
| 3.1 | 21.9 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
| 3.1 | 9.3 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
| 3.0 | 11.9 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
| 2.7 | 8.1 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
| 2.6 | 448.4 | GO:0072562 | blood microparticle(GO:0072562) |
| 2.5 | 7.6 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
| 2.4 | 28.4 | GO:0097486 | multivesicular body lumen(GO:0097486) |
| 2.3 | 9.4 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
| 2.3 | 11.6 | GO:0019814 | immunoglobulin complex(GO:0019814) |
| 2.3 | 18.2 | GO:0005833 | hemoglobin complex(GO:0005833) |
| 2.1 | 2.1 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
| 2.0 | 7.9 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
| 1.9 | 7.8 | GO:1990879 | CST complex(GO:1990879) |
| 1.9 | 11.6 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
| 1.9 | 5.7 | GO:0070701 | mucus layer(GO:0070701) |
| 1.8 | 9.2 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) |
| 1.8 | 9.1 | GO:0005579 | membrane attack complex(GO:0005579) |
| 1.8 | 10.5 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
| 1.7 | 8.7 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
| 1.7 | 5.1 | GO:0031251 | PAN complex(GO:0031251) |
| 1.7 | 11.8 | GO:1990037 | Lewy body core(GO:1990037) |
| 1.7 | 8.4 | GO:0036398 | TCR signalosome(GO:0036398) |
| 1.7 | 11.7 | GO:1990130 | Iml1 complex(GO:1990130) |
| 1.6 | 4.9 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
| 1.6 | 4.8 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
| 1.5 | 6.2 | GO:1990876 | cytoplasmic side of nuclear pore(GO:1990876) |
| 1.5 | 23.0 | GO:0005861 | troponin complex(GO:0005861) |
| 1.5 | 23.0 | GO:0042627 | chylomicron(GO:0042627) |
| 1.5 | 4.6 | GO:0043293 | apoptosome(GO:0043293) |
| 1.5 | 6.0 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
| 1.5 | 7.4 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
| 1.5 | 26.4 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 1.5 | 4.4 | GO:0031085 | BLOC-3 complex(GO:0031085) |
| 1.4 | 15.9 | GO:0044666 | MLL3/4 complex(GO:0044666) |
| 1.4 | 4.3 | GO:1903349 | omegasome membrane(GO:1903349) |
| 1.4 | 7.1 | GO:0042825 | TAP complex(GO:0042825) |
| 1.4 | 5.7 | GO:0000801 | central element(GO:0000801) |
| 1.4 | 4.2 | GO:0098536 | deuterosome(GO:0098536) |
| 1.4 | 8.4 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
| 1.4 | 34.3 | GO:0001891 | phagocytic cup(GO:0001891) |
| 1.4 | 33.8 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
| 1.3 | 26.9 | GO:0031932 | TORC2 complex(GO:0031932) |
| 1.3 | 3.8 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
| 1.2 | 45.8 | GO:0005859 | muscle myosin complex(GO:0005859) |
| 1.2 | 4.9 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
| 1.2 | 10.9 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
| 1.2 | 4.8 | GO:0002139 | stereocilia coupling link(GO:0002139) |
| 1.2 | 8.3 | GO:1990745 | EARP complex(GO:1990745) |
| 1.2 | 8.3 | GO:0036157 | outer dynein arm(GO:0036157) |
| 1.2 | 3.5 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
| 1.2 | 2.3 | GO:0031527 | filopodium membrane(GO:0031527) |
| 1.1 | 11.4 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
| 1.1 | 3.4 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
| 1.1 | 4.5 | GO:0097443 | sorting endosome(GO:0097443) |
| 1.1 | 5.5 | GO:0034464 | BBSome(GO:0034464) |
| 1.1 | 15.2 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 1.1 | 2.2 | GO:0044305 | calyx of Held(GO:0044305) |
| 1.1 | 8.5 | GO:1903439 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
| 1.0 | 9.4 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 1.0 | 2.1 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
| 1.0 | 6.1 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 1.0 | 144.3 | GO:0043202 | lysosomal lumen(GO:0043202) |
| 1.0 | 19.4 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 1.0 | 1.0 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
| 1.0 | 7.0 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
| 1.0 | 8.0 | GO:0045179 | apical cortex(GO:0045179) |
| 1.0 | 78.5 | GO:0005796 | Golgi lumen(GO:0005796) |
| 1.0 | 6.9 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
| 1.0 | 3.0 | GO:0044609 | DBIRD complex(GO:0044609) |
| 1.0 | 9.8 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 1.0 | 4.8 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
| 0.9 | 30.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.9 | 11.3 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 0.9 | 2.8 | GO:0043511 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
| 0.9 | 3.6 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.9 | 9.9 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
| 0.9 | 8.0 | GO:0071953 | elastic fiber(GO:0071953) |
| 0.9 | 0.9 | GO:0042025 | viral replication complex(GO:0019034) host cell nucleus(GO:0042025) host cell nuclear part(GO:0044094) |
| 0.9 | 14.8 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 0.9 | 4.3 | GO:1990031 | pinceau fiber(GO:1990031) |
| 0.9 | 2.6 | GO:0035525 | NF-kappaB p50/p65 complex(GO:0035525) |
| 0.9 | 5.1 | GO:0032009 | early phagosome(GO:0032009) |
| 0.8 | 39.0 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.8 | 3.4 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
| 0.8 | 5.0 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
| 0.8 | 27.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 0.8 | 3.3 | GO:0071546 | pi-body(GO:0071546) |
| 0.8 | 7.5 | GO:0070652 | HAUS complex(GO:0070652) |
| 0.8 | 31.3 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.8 | 2.4 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
| 0.8 | 65.8 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
| 0.8 | 2.4 | GO:0030312 | external encapsulating structure(GO:0030312) |
| 0.8 | 2.4 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
| 0.8 | 3.9 | GO:0060171 | stereocilium membrane(GO:0060171) |
| 0.8 | 1.6 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
| 0.8 | 9.3 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
| 0.8 | 5.4 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 0.8 | 2.3 | GO:0034657 | GID complex(GO:0034657) |
| 0.8 | 8.5 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 0.8 | 1.5 | GO:0043159 | acrosomal matrix(GO:0043159) |
| 0.7 | 2.2 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
| 0.7 | 2.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
| 0.7 | 5.5 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
| 0.7 | 3.4 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 0.7 | 4.0 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
| 0.7 | 5.4 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
| 0.7 | 2.7 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
| 0.7 | 4.7 | GO:0097165 | nuclear stress granule(GO:0097165) |
| 0.7 | 2.0 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
| 0.6 | 2.6 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) |
| 0.6 | 16.6 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
| 0.6 | 4.4 | GO:0033391 | chromatoid body(GO:0033391) |
| 0.6 | 3.2 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
| 0.6 | 13.8 | GO:0031528 | microvillus membrane(GO:0031528) |
| 0.6 | 3.1 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
| 0.6 | 9.8 | GO:0035631 | CD40 receptor complex(GO:0035631) |
| 0.6 | 20.7 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.6 | 3.0 | GO:0030314 | junctional membrane complex(GO:0030314) |
| 0.6 | 3.6 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
| 0.6 | 62.7 | GO:0035579 | specific granule membrane(GO:0035579) |
| 0.6 | 1.2 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.6 | 4.6 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
| 0.6 | 1.7 | GO:0035517 | PR-DUB complex(GO:0035517) |
| 0.6 | 6.8 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.6 | 0.6 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
| 0.6 | 134.7 | GO:0009897 | external side of plasma membrane(GO:0009897) |
| 0.6 | 10.6 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
| 0.6 | 9.4 | GO:0031904 | endosome lumen(GO:0031904) |
| 0.5 | 4.4 | GO:0030891 | VCB complex(GO:0030891) |
| 0.5 | 16.9 | GO:0034706 | sodium channel complex(GO:0034706) |
| 0.5 | 3.7 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
| 0.5 | 6.9 | GO:0001741 | XY body(GO:0001741) |
| 0.5 | 1.6 | GO:0014802 | terminal cisterna(GO:0014802) |
| 0.5 | 16.9 | GO:0008305 | integrin complex(GO:0008305) |
| 0.5 | 5.2 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
| 0.5 | 2.1 | GO:0097413 | Lewy body(GO:0097413) |
| 0.5 | 2.6 | GO:0071797 | LUBAC complex(GO:0071797) |
| 0.5 | 4.2 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
| 0.5 | 7.8 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.5 | 8.3 | GO:0035102 | PRC1 complex(GO:0035102) |
| 0.5 | 1.0 | GO:0016514 | SWI/SNF complex(GO:0016514) |
| 0.5 | 2.1 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.5 | 2.5 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
| 0.5 | 3.0 | GO:1990769 | proximal neuron projection(GO:1990769) |
| 0.5 | 7.5 | GO:0016461 | unconventional myosin complex(GO:0016461) |
| 0.5 | 5.5 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.5 | 7.9 | GO:0097225 | sperm midpiece(GO:0097225) |
| 0.5 | 4.9 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.5 | 16.1 | GO:0005902 | microvillus(GO:0005902) |
| 0.5 | 5.8 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.5 | 13.0 | GO:0009925 | basal plasma membrane(GO:0009925) |
| 0.5 | 0.5 | GO:0097524 | sperm plasma membrane(GO:0097524) |
| 0.5 | 1.4 | GO:0036284 | tubulobulbar complex(GO:0036284) |
| 0.5 | 1.9 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
| 0.5 | 1.9 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
| 0.5 | 6.0 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.5 | 3.2 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 0.5 | 0.9 | GO:0097209 | epidermal lamellar body(GO:0097209) |
| 0.4 | 2.7 | GO:0000322 | storage vacuole(GO:0000322) |
| 0.4 | 2.2 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
| 0.4 | 2.2 | GO:0032444 | activin responsive factor complex(GO:0032444) |
| 0.4 | 3.4 | GO:0072487 | MSL complex(GO:0072487) |
| 0.4 | 34.5 | GO:0034707 | chloride channel complex(GO:0034707) |
| 0.4 | 4.2 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
| 0.4 | 1.2 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
| 0.4 | 6.6 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
| 0.4 | 2.9 | GO:0005587 | collagen type IV trimer(GO:0005587) |
| 0.4 | 2.8 | GO:0035976 | AP1 complex(GO:0035976) |
| 0.4 | 7.1 | GO:0005922 | connexon complex(GO:0005922) |
| 0.4 | 53.0 | GO:0032587 | ruffle membrane(GO:0032587) |
| 0.4 | 1.6 | GO:0032584 | growth cone membrane(GO:0032584) |
| 0.4 | 498.5 | GO:0005615 | extracellular space(GO:0005615) |
| 0.4 | 11.9 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
| 0.4 | 2.7 | GO:0005677 | chromatin silencing complex(GO:0005677) |
| 0.4 | 3.4 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
| 0.4 | 1.5 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
| 0.4 | 18.0 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.4 | 1.1 | GO:0005745 | m-AAA complex(GO:0005745) |
| 0.4 | 3.7 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.4 | 0.7 | GO:0032426 | stereocilium tip(GO:0032426) |
| 0.4 | 1.8 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
| 0.4 | 1.1 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.3 | 4.9 | GO:0070069 | cytochrome complex(GO:0070069) |
| 0.3 | 5.2 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.3 | 3.4 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
| 0.3 | 8.0 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 0.3 | 1.3 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 0.3 | 4.0 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.3 | 0.7 | GO:0031310 | intrinsic component of vacuolar membrane(GO:0031310) |
| 0.3 | 1.0 | GO:0030689 | Noc complex(GO:0030689) |
| 0.3 | 2.5 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 0.3 | 3.1 | GO:0032039 | integrator complex(GO:0032039) |
| 0.3 | 1.8 | GO:0042588 | zymogen granule(GO:0042588) |
| 0.3 | 0.9 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
| 0.3 | 1.8 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
| 0.3 | 20.3 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
| 0.3 | 3.3 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.3 | 1.1 | GO:0048179 | activin receptor complex(GO:0048179) |
| 0.3 | 6.6 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
| 0.3 | 3.7 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
| 0.3 | 1.7 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
| 0.3 | 3.1 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 0.3 | 13.5 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
| 0.3 | 7.5 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
| 0.3 | 1.3 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
| 0.3 | 0.5 | GO:0000938 | GARP complex(GO:0000938) |
| 0.3 | 1.3 | GO:0045257 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
| 0.3 | 22.1 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.3 | 1.5 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 0.3 | 1.3 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
| 0.3 | 1.5 | GO:0070449 | elongin complex(GO:0070449) |
| 0.2 | 32.2 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
| 0.2 | 3.2 | GO:0000786 | nucleosome(GO:0000786) |
| 0.2 | 1.7 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
| 0.2 | 1.2 | GO:0032982 | myosin filament(GO:0032982) |
| 0.2 | 0.9 | GO:0005960 | glycine cleavage complex(GO:0005960) |
| 0.2 | 10.0 | GO:0005901 | caveola(GO:0005901) |
| 0.2 | 0.5 | GO:0042827 | platelet dense granule membrane(GO:0031088) platelet dense granule(GO:0042827) |
| 0.2 | 0.7 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
| 0.2 | 6.4 | GO:0000791 | euchromatin(GO:0000791) |
| 0.2 | 8.4 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
| 0.2 | 2.4 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.2 | 308.0 | GO:0031226 | intrinsic component of plasma membrane(GO:0031226) |
| 0.2 | 1.8 | GO:0030126 | COPI vesicle coat(GO:0030126) |
| 0.2 | 7.1 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
| 0.2 | 0.2 | GO:0033646 | host cell cytoplasm(GO:0030430) host intracellular part(GO:0033646) host cell cytoplasm part(GO:0033655) intracellular region of host(GO:0043656) |
| 0.2 | 1.9 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
| 0.2 | 9.8 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
| 0.2 | 0.7 | GO:0030870 | Mre11 complex(GO:0030870) |
| 0.2 | 23.9 | GO:0016605 | PML body(GO:0016605) |
| 0.2 | 0.9 | GO:0005858 | axonemal dynein complex(GO:0005858) |
| 0.2 | 2.9 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
| 0.2 | 0.3 | GO:0033011 | perinuclear theca(GO:0033011) cytoskeletal calyx(GO:0033150) |
| 0.2 | 0.2 | GO:0043260 | laminin-11 complex(GO:0043260) |
| 0.2 | 3.9 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
| 0.2 | 0.3 | GO:1990393 | 3M complex(GO:1990393) |
| 0.2 | 0.3 | GO:0035189 | Rb-E2F complex(GO:0035189) |
| 0.2 | 0.9 | GO:0032590 | dendrite membrane(GO:0032590) |
| 0.1 | 3.7 | GO:0071565 | nBAF complex(GO:0071565) |
| 0.1 | 8.4 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
| 0.1 | 1.5 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
| 0.1 | 0.8 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.1 | 2.5 | GO:0005640 | nuclear outer membrane(GO:0005640) |
| 0.1 | 0.5 | GO:0034457 | Mpp10 complex(GO:0034457) |
| 0.1 | 1.1 | GO:0016580 | Sin3 complex(GO:0016580) |
| 0.1 | 1.5 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.1 | 0.6 | GO:0070847 | core mediator complex(GO:0070847) |
| 0.1 | 4.4 | GO:0016459 | myosin complex(GO:0016459) |
| 0.1 | 2.6 | GO:0035869 | ciliary transition zone(GO:0035869) |
| 0.1 | 0.4 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
| 0.1 | 0.2 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
| 0.1 | 0.6 | GO:0005594 | collagen type IX trimer(GO:0005594) |
| 0.1 | 1.7 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.1 | 2.3 | GO:0035145 | exon-exon junction complex(GO:0035145) |
| 0.1 | 0.4 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
| 0.1 | 0.8 | GO:0031083 | BLOC-1 complex(GO:0031083) |
| 0.1 | 0.3 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
| 0.1 | 5.0 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.1 | 0.2 | GO:0033593 | BRCA2-MAGE-D1 complex(GO:0033593) |
| 0.1 | 3.1 | GO:0000118 | histone deacetylase complex(GO:0000118) |
| 0.1 | 3.8 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.1 | 0.7 | GO:0000145 | exocyst(GO:0000145) |
| 0.1 | 0.6 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
| 0.1 | 8.8 | GO:0016324 | apical plasma membrane(GO:0016324) |
| 0.1 | 0.2 | GO:0034455 | t-UTP complex(GO:0034455) |
| 0.0 | 1.4 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
| 0.0 | 0.1 | GO:0008278 | cohesin complex(GO:0008278) |
| 0.0 | 0.2 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 0.0 | 5.1 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
| 0.0 | 0.4 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 0.0 | 0.0 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
| 0.0 | 0.2 | GO:0001520 | outer dense fiber(GO:0001520) |
| 0.0 | 0.1 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
| 0.0 | 0.3 | GO:0016328 | lateral plasma membrane(GO:0016328) |
Gene overrepresentation in molecular function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 12.8 | 769.8 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 12.5 | 50.1 | GO:0033897 | ribonuclease T2 activity(GO:0033897) |
| 9.8 | 29.3 | GO:0061609 | fructose-1-phosphate aldolase activity(GO:0061609) |
| 8.8 | 35.2 | GO:0004341 | gluconolactonase activity(GO:0004341) |
| 6.3 | 56.6 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
| 6.0 | 23.9 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
| 5.6 | 28.0 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
| 5.4 | 211.9 | GO:0042605 | peptide antigen binding(GO:0042605) |
| 5.4 | 16.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 5.2 | 25.9 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
| 5.2 | 20.7 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
| 5.1 | 40.7 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 5.1 | 20.3 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
| 5.0 | 15.1 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
| 5.0 | 14.9 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
| 4.8 | 28.6 | GO:0030172 | troponin C binding(GO:0030172) |
| 4.8 | 19.0 | GO:0005471 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
| 4.7 | 14.0 | GO:0017129 | triglyceride binding(GO:0017129) |
| 4.5 | 13.5 | GO:0031755 | endothelial differentiation G-protein coupled receptor binding(GO:0031753) Edg-2 lysophosphatidic acid receptor binding(GO:0031755) |
| 4.5 | 17.9 | GO:0019862 | IgA binding(GO:0019862) |
| 4.4 | 4.4 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
| 4.3 | 17.1 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
| 4.2 | 12.5 | GO:0052816 | medium-chain acyl-CoA hydrolase activity(GO:0052815) long-chain acyl-CoA hydrolase activity(GO:0052816) |
| 4.0 | 16.1 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
| 4.0 | 19.8 | GO:0004771 | sterol esterase activity(GO:0004771) |
| 3.9 | 23.6 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
| 3.9 | 31.1 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 3.8 | 11.5 | GO:0004051 | arachidonate 5-lipoxygenase activity(GO:0004051) |
| 3.8 | 15.2 | GO:0061769 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
| 3.8 | 556.1 | GO:0003823 | antigen binding(GO:0003823) |
| 3.7 | 15.0 | GO:0097001 | ceramide binding(GO:0097001) |
| 3.7 | 11.0 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
| 3.6 | 21.5 | GO:0031013 | troponin I binding(GO:0031013) |
| 3.6 | 14.2 | GO:0030492 | hemoglobin binding(GO:0030492) |
| 3.5 | 31.2 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
| 3.4 | 10.3 | GO:0009032 | thymidine phosphorylase activity(GO:0009032) pyrimidine-nucleoside phosphorylase activity(GO:0016154) |
| 3.4 | 23.9 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
| 3.4 | 13.6 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
| 3.4 | 30.5 | GO:0043426 | MRF binding(GO:0043426) |
| 3.4 | 13.5 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
| 3.4 | 13.4 | GO:0030107 | HLA-A specific inhibitory MHC class I receptor activity(GO:0030107) |
| 3.4 | 16.8 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
| 3.3 | 10.0 | GO:0016784 | 3-mercaptopyruvate sulfurtransferase activity(GO:0016784) |
| 3.3 | 10.0 | GO:0016160 | alpha-amylase activity(GO:0004556) amylase activity(GO:0016160) |
| 3.3 | 49.9 | GO:0005344 | oxygen transporter activity(GO:0005344) |
| 3.3 | 13.1 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
| 3.3 | 19.6 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
| 3.2 | 38.9 | GO:0008430 | selenium binding(GO:0008430) |
| 3.2 | 12.7 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
| 3.2 | 9.5 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
| 3.1 | 12.5 | GO:0070404 | NADH binding(GO:0070404) |
| 3.1 | 9.2 | GO:0004056 | argininosuccinate lyase activity(GO:0004056) |
| 3.1 | 12.3 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
| 3.0 | 18.2 | GO:0032038 | myosin II heavy chain binding(GO:0032038) |
| 3.0 | 11.9 | GO:0061656 | SUMO conjugating enzyme activity(GO:0061656) |
| 3.0 | 8.9 | GO:0036134 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
| 2.9 | 23.0 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
| 2.9 | 8.6 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
| 2.9 | 2.9 | GO:0019770 | IgG receptor activity(GO:0019770) |
| 2.8 | 16.7 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
| 2.8 | 16.6 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
| 2.7 | 21.4 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
| 2.7 | 16.0 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
| 2.6 | 10.3 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
| 2.6 | 12.9 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
| 2.6 | 12.8 | GO:0030375 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
| 2.5 | 7.6 | GO:0042289 | MHC class II protein binding(GO:0042289) |
| 2.5 | 7.5 | GO:0004912 | interleukin-3 receptor activity(GO:0004912) |
| 2.5 | 12.5 | GO:0016749 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
| 2.5 | 5.0 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
| 2.5 | 14.8 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
| 2.5 | 7.4 | GO:0008431 | vitamin E binding(GO:0008431) |
| 2.5 | 24.5 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
| 2.4 | 2.4 | GO:0001727 | lipid kinase activity(GO:0001727) |
| 2.4 | 9.8 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
| 2.4 | 21.2 | GO:0032190 | acrosin binding(GO:0032190) |
| 2.3 | 20.7 | GO:0034235 | GPI anchor binding(GO:0034235) |
| 2.3 | 27.6 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
| 2.3 | 48.2 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 2.3 | 27.5 | GO:0042608 | T cell receptor binding(GO:0042608) |
| 2.3 | 13.7 | GO:0003796 | lysozyme activity(GO:0003796) |
| 2.2 | 4.5 | GO:0031692 | alpha-1B adrenergic receptor binding(GO:0031692) |
| 2.2 | 18.0 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
| 2.2 | 26.7 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
| 2.2 | 6.7 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
| 2.2 | 15.5 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
| 2.2 | 11.1 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
| 2.2 | 13.3 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 2.2 | 4.4 | GO:0050436 | microfibril binding(GO:0050436) |
| 2.2 | 6.6 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
| 2.2 | 24.2 | GO:0031433 | telethonin binding(GO:0031433) |
| 2.2 | 11.0 | GO:0001132 | RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly(GO:0001129) RNA polymerase II transcription factor activity, TBP-class protein binding(GO:0001132) |
| 2.2 | 6.5 | GO:0004998 | transferrin receptor activity(GO:0004998) |
| 2.2 | 6.5 | GO:0019959 | interleukin-8 binding(GO:0019959) |
| 2.1 | 17.2 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
| 2.1 | 12.8 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
| 2.1 | 8.5 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
| 2.1 | 6.3 | GO:0035276 | ethanol binding(GO:0035276) |
| 2.1 | 12.4 | GO:0070004 | cysteine-type carboxypeptidase activity(GO:0016807) cysteine-type exopeptidase activity(GO:0070004) |
| 2.1 | 6.2 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
| 2.0 | 2.0 | GO:0015925 | galactosidase activity(GO:0015925) |
| 2.0 | 8.1 | GO:0061714 | folic acid receptor activity(GO:0061714) |
| 2.0 | 9.9 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
| 2.0 | 9.9 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
| 2.0 | 5.9 | GO:0061697 | protein-malonyllysine demalonylase activity(GO:0036054) protein-succinyllysine desuccinylase activity(GO:0036055) protein-glutaryllysine deglutarylase activity(GO:0061697) |
| 2.0 | 13.7 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
| 1.9 | 7.6 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
| 1.9 | 38.2 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 1.9 | 24.6 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
| 1.9 | 9.4 | GO:0004370 | glycerol kinase activity(GO:0004370) |
| 1.9 | 5.6 | GO:0016882 | cyclo-ligase activity(GO:0016882) 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
| 1.9 | 5.6 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
| 1.9 | 1.9 | GO:0051373 | FATZ binding(GO:0051373) |
| 1.8 | 5.5 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
| 1.8 | 12.8 | GO:1904288 | BAT3 complex binding(GO:1904288) |
| 1.8 | 5.4 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
| 1.8 | 7.2 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
| 1.8 | 7.2 | GO:0071723 | lipopeptide binding(GO:0071723) |
| 1.8 | 3.6 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
| 1.8 | 5.4 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
| 1.8 | 9.0 | GO:0051120 | hepoxilin A3 synthase activity(GO:0051120) |
| 1.8 | 12.4 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
| 1.8 | 19.3 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
| 1.7 | 22.6 | GO:0019864 | IgG binding(GO:0019864) |
| 1.7 | 24.3 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 1.7 | 3.5 | GO:0004923 | leukemia inhibitory factor receptor activity(GO:0004923) |
| 1.7 | 25.7 | GO:0019957 | C-C chemokine binding(GO:0019957) |
| 1.7 | 174.7 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 1.7 | 5.1 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
| 1.7 | 12.0 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
| 1.7 | 8.5 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
| 1.7 | 38.9 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
| 1.7 | 1.7 | GO:0070644 | vitamin D response element binding(GO:0070644) |
| 1.7 | 18.6 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 1.7 | 6.7 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
| 1.7 | 6.7 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
| 1.7 | 5.0 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
| 1.7 | 10.0 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
| 1.7 | 15.0 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 1.7 | 5.0 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
| 1.7 | 8.3 | GO:0004803 | transposase activity(GO:0004803) |
| 1.6 | 8.2 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
| 1.6 | 9.8 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 1.6 | 4.9 | GO:0070362 | mitochondrial light strand promoter anti-sense binding(GO:0070361) mitochondrial heavy strand promoter anti-sense binding(GO:0070362) mitochondrial heavy strand promoter sense binding(GO:0070364) |
| 1.6 | 4.9 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
| 1.6 | 3.2 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
| 1.6 | 6.4 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
| 1.6 | 6.4 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
| 1.6 | 9.6 | GO:0016402 | pristanoyl-CoA oxidase activity(GO:0016402) |
| 1.6 | 6.4 | GO:0005124 | scavenger receptor binding(GO:0005124) |
| 1.6 | 4.8 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
| 1.6 | 1.6 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
| 1.6 | 4.7 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
| 1.6 | 9.4 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
| 1.6 | 3.1 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
| 1.5 | 4.6 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
| 1.5 | 3.1 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
| 1.5 | 4.6 | GO:0004967 | glucagon receptor activity(GO:0004967) |
| 1.5 | 9.2 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
| 1.5 | 4.6 | GO:0001861 | complement component C4b receptor activity(GO:0001861) complement component C3b receptor activity(GO:0004877) |
| 1.5 | 4.6 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
| 1.5 | 7.6 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
| 1.5 | 4.5 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
| 1.5 | 4.5 | GO:0030350 | iron-responsive element binding(GO:0030350) |
| 1.5 | 7.5 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
| 1.5 | 13.3 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
| 1.5 | 22.0 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
| 1.5 | 10.3 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
| 1.5 | 8.8 | GO:0004630 | phospholipase D activity(GO:0004630) |
| 1.5 | 4.4 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
| 1.4 | 18.8 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
| 1.4 | 11.5 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
| 1.4 | 7.2 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
| 1.4 | 5.7 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
| 1.4 | 7.2 | GO:0004522 | ribonuclease A activity(GO:0004522) |
| 1.4 | 4.3 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
| 1.4 | 8.5 | GO:0090554 | phosphatidylcholine-translocating ATPase activity(GO:0090554) |
| 1.4 | 317.6 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 1.4 | 9.9 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 1.4 | 9.8 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 1.4 | 4.2 | GO:0004336 | galactosylceramidase activity(GO:0004336) |
| 1.4 | 4.2 | GO:0046997 | sarcosine dehydrogenase activity(GO:0008480) oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
| 1.4 | 16.6 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
| 1.4 | 6.9 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
| 1.4 | 9.6 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
| 1.4 | 8.1 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
| 1.3 | 17.5 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
| 1.3 | 4.0 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
| 1.3 | 2.6 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
| 1.3 | 8.9 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
| 1.3 | 10.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
| 1.3 | 10.2 | GO:0045159 | myosin II binding(GO:0045159) |
| 1.3 | 5.1 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 1.3 | 13.8 | GO:0070324 | thyroid hormone binding(GO:0070324) |
| 1.3 | 10.0 | GO:0004645 | phosphorylase activity(GO:0004645) |
| 1.2 | 3.7 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
| 1.2 | 3.7 | GO:0052739 | phosphatidylserine 1-acylhydrolase activity(GO:0052739) |
| 1.2 | 4.9 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
| 1.2 | 7.4 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
| 1.2 | 15.9 | GO:0019841 | retinol binding(GO:0019841) |
| 1.2 | 14.5 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
| 1.2 | 10.8 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
| 1.2 | 7.1 | GO:0001007 | transcription factor activity, RNA polymerase III transcription factor binding(GO:0001007) |
| 1.2 | 11.9 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 1.2 | 19.9 | GO:0003680 | AT DNA binding(GO:0003680) |
| 1.2 | 19.9 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
| 1.2 | 4.7 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 1.2 | 12.7 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
| 1.2 | 16.1 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
| 1.1 | 1.1 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
| 1.1 | 8.0 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
| 1.1 | 3.4 | GO:0052854 | (S)-2-hydroxy-acid oxidase activity(GO:0003973) oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) very-long-chain-(S)-2-hydroxy-acid oxidase activity(GO:0052852) long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity(GO:0052853) medium-chain-(S)-2-hydroxy-acid oxidase activity(GO:0052854) |
| 1.1 | 6.9 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
| 1.1 | 10.1 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
| 1.1 | 10.1 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
| 1.1 | 13.4 | GO:0032052 | bile acid binding(GO:0032052) |
| 1.1 | 6.7 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
| 1.1 | 1.1 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
| 1.1 | 8.8 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
| 1.1 | 5.5 | GO:0070051 | fibrinogen binding(GO:0070051) |
| 1.1 | 6.5 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 1.1 | 4.3 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
| 1.1 | 1.1 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
| 1.1 | 8.6 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
| 1.1 | 3.2 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
| 1.1 | 8.5 | GO:0097643 | amylin receptor activity(GO:0097643) |
| 1.1 | 30.7 | GO:0001972 | retinoic acid binding(GO:0001972) |
| 1.1 | 6.3 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
| 1.0 | 20.9 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
| 1.0 | 14.6 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
| 1.0 | 2.1 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
| 1.0 | 3.1 | GO:0015389 | pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
| 1.0 | 6.2 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 1.0 | 5.2 | GO:0004905 | type I interferon receptor activity(GO:0004905) |
| 1.0 | 21.7 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) serine-type exopeptidase activity(GO:0070008) |
| 1.0 | 6.2 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
| 1.0 | 1.0 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
| 1.0 | 19.5 | GO:0038191 | neuropilin binding(GO:0038191) |
| 1.0 | 2.1 | GO:0022840 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
| 1.0 | 1.0 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
| 1.0 | 4.1 | GO:0015254 | glycerol channel activity(GO:0015254) |
| 1.0 | 8.1 | GO:0015232 | heme transporter activity(GO:0015232) |
| 1.0 | 3.0 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
| 1.0 | 21.0 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 1.0 | 9.0 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
| 1.0 | 16.8 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
| 1.0 | 4.9 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
| 1.0 | 2.0 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
| 1.0 | 1.0 | GO:0008969 | phosphohistidine phosphatase activity(GO:0008969) |
| 1.0 | 13.6 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 1.0 | 2.9 | GO:0032090 | Pyrin domain binding(GO:0032090) |
| 1.0 | 8.6 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 1.0 | 3.8 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
| 0.9 | 7.6 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
| 0.9 | 2.8 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
| 0.9 | 1.9 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) |
| 0.9 | 9.4 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
| 0.9 | 10.3 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
| 0.9 | 2.8 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
| 0.9 | 3.7 | GO:0051380 | norepinephrine binding(GO:0051380) |
| 0.9 | 6.5 | GO:0005497 | androgen binding(GO:0005497) |
| 0.9 | 3.7 | GO:0008832 | dGTPase activity(GO:0008832) triphosphoric monoester hydrolase activity(GO:0016793) guanyl deoxyribonucleotide binding(GO:0032560) dGTP binding(GO:0032567) |
| 0.9 | 3.7 | GO:0032810 | sterol response element binding(GO:0032810) |
| 0.9 | 4.6 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
| 0.9 | 29.1 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
| 0.9 | 3.6 | GO:0005151 | interleukin-1, Type II receptor binding(GO:0005151) |
| 0.9 | 4.5 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
| 0.9 | 8.1 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
| 0.9 | 5.4 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
| 0.9 | 1.8 | GO:0070905 | serine binding(GO:0070905) |
| 0.9 | 6.3 | GO:0005534 | galactose binding(GO:0005534) |
| 0.9 | 8.0 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
| 0.9 | 5.3 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 0.9 | 6.9 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
| 0.9 | 0.9 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
| 0.9 | 4.3 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) |
| 0.9 | 4.3 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
| 0.9 | 4.3 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
| 0.9 | 10.3 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
| 0.9 | 3.4 | GO:0002046 | opsin binding(GO:0002046) |
| 0.9 | 3.4 | GO:1904408 | dihydronicotinamide riboside quinone reductase activity(GO:0001512) melatonin binding(GO:1904408) |
| 0.8 | 3.4 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
| 0.8 | 12.7 | GO:0003993 | acid phosphatase activity(GO:0003993) |
| 0.8 | 4.2 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 0.8 | 4.2 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
| 0.8 | 3.4 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
| 0.8 | 2.5 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
| 0.8 | 5.8 | GO:0001515 | opioid peptide activity(GO:0001515) |
| 0.8 | 7.5 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
| 0.8 | 5.8 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.8 | 9.9 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
| 0.8 | 28.8 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
| 0.8 | 14.8 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.8 | 0.8 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
| 0.8 | 5.7 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
| 0.8 | 2.4 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
| 0.8 | 2.4 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
| 0.8 | 4.0 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
| 0.8 | 2.4 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
| 0.8 | 7.2 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.8 | 4.0 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
| 0.8 | 3.9 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
| 0.8 | 3.2 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
| 0.8 | 4.7 | GO:0016672 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) |
| 0.8 | 3.1 | GO:0048039 | ubiquinone binding(GO:0048039) |
| 0.8 | 3.1 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 0.8 | 7.8 | GO:0004568 | chitinase activity(GO:0004568) chitin binding(GO:0008061) |
| 0.8 | 3.1 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
| 0.8 | 2.3 | GO:0016936 | galactoside binding(GO:0016936) |
| 0.8 | 9.9 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
| 0.8 | 9.9 | GO:0009374 | biotin binding(GO:0009374) |
| 0.8 | 3.0 | GO:0005333 | norepinephrine transmembrane transporter activity(GO:0005333) |
| 0.8 | 40.3 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
| 0.8 | 1.5 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
| 0.8 | 12.1 | GO:0015923 | mannosidase activity(GO:0015923) |
| 0.8 | 39.2 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.8 | 4.5 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
| 0.8 | 6.0 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
| 0.8 | 2.3 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
| 0.7 | 3.0 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
| 0.7 | 15.7 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
| 0.7 | 2.2 | GO:0005174 | CD40 receptor binding(GO:0005174) |
| 0.7 | 3.0 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
| 0.7 | 2.2 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
| 0.7 | 2.9 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
| 0.7 | 1.5 | GO:0034711 | inhibin binding(GO:0034711) |
| 0.7 | 3.6 | GO:0004368 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
| 0.7 | 2.9 | GO:1904680 | peptide transporter activity(GO:0015197) peptide transmembrane transporter activity(GO:1904680) |
| 0.7 | 2.9 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
| 0.7 | 3.6 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
| 0.7 | 0.7 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
| 0.7 | 3.6 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
| 0.7 | 4.3 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 0.7 | 2.8 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) |
| 0.7 | 2.1 | GO:0019981 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) ciliary neurotrophic factor binding(GO:0070119) |
| 0.7 | 5.6 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
| 0.7 | 2.8 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
| 0.7 | 2.1 | GO:0000773 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
| 0.7 | 2.8 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
| 0.7 | 15.2 | GO:0030275 | LRR domain binding(GO:0030275) |
| 0.7 | 3.4 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
| 0.7 | 2.0 | GO:0032093 | SAM domain binding(GO:0032093) |
| 0.7 | 10.9 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
| 0.7 | 2.0 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
| 0.7 | 5.4 | GO:0030284 | estrogen receptor activity(GO:0030284) |
| 0.7 | 12.8 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.7 | 2.0 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
| 0.7 | 3.3 | GO:0016803 | ether hydrolase activity(GO:0016803) |
| 0.7 | 5.3 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
| 0.7 | 81.5 | GO:0005179 | hormone activity(GO:0005179) |
| 0.7 | 7.3 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
| 0.7 | 2.6 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
| 0.7 | 1.3 | GO:0030957 | Tat protein binding(GO:0030957) |
| 0.7 | 2.0 | GO:0005055 | laminin receptor activity(GO:0005055) |
| 0.6 | 1.9 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
| 0.6 | 3.2 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
| 0.6 | 1.9 | GO:0097677 | STAT family protein binding(GO:0097677) |
| 0.6 | 4.5 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
| 0.6 | 4.5 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
| 0.6 | 2.6 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
| 0.6 | 9.0 | GO:0015368 | calcium:cation antiporter activity(GO:0015368) |
| 0.6 | 5.7 | GO:0050682 | AF-2 domain binding(GO:0050682) |
| 0.6 | 1.9 | GO:1904928 | coreceptor activity involved in canonical Wnt signaling pathway(GO:1904928) |
| 0.6 | 8.2 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
| 0.6 | 18.3 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
| 0.6 | 1.9 | GO:0001847 | opsonin receptor activity(GO:0001847) |
| 0.6 | 1.9 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
| 0.6 | 2.5 | GO:0042015 | interleukin-20 binding(GO:0042015) |
| 0.6 | 1.9 | GO:0031711 | angiotensin type I receptor activity(GO:0001596) bradykinin receptor binding(GO:0031711) |
| 0.6 | 6.8 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
| 0.6 | 10.5 | GO:0010857 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) calcium-dependent protein kinase activity(GO:0010857) |
| 0.6 | 10.5 | GO:0001614 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
| 0.6 | 19.4 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.6 | 3.0 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
| 0.6 | 2.4 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
| 0.6 | 3.0 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
| 0.6 | 3.0 | GO:0005119 | smoothened binding(GO:0005119) |
| 0.6 | 1.8 | GO:0052725 | inositol tetrakisphosphate 1-kinase activity(GO:0047325) inositol tetrakisphosphate kinase activity(GO:0051765) inositol-1,3,4-trisphosphate 6-kinase activity(GO:0052725) inositol-1,3,4-trisphosphate 5-kinase activity(GO:0052726) inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity(GO:0052825) inositol pentakisphosphate phosphatase activity(GO:0052827) inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity(GO:0052830) inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity(GO:0052831) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) |
| 0.6 | 4.8 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
| 0.6 | 11.9 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.6 | 9.5 | GO:0042287 | MHC protein binding(GO:0042287) |
| 0.6 | 1.8 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
| 0.6 | 1.2 | GO:0002060 | purine nucleobase binding(GO:0002060) |
| 0.6 | 4.7 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
| 0.6 | 8.7 | GO:0017136 | NAD-dependent histone deacetylase activity(GO:0017136) |
| 0.6 | 3.5 | GO:0060229 | lipase activator activity(GO:0060229) |
| 0.6 | 2.9 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
| 0.6 | 7.5 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
| 0.6 | 2.9 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
| 0.6 | 2.3 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
| 0.6 | 0.6 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
| 0.6 | 9.6 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
| 0.6 | 3.4 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
| 0.6 | 3.4 | GO:0071253 | connexin binding(GO:0071253) |
| 0.6 | 13.0 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
| 0.6 | 1.7 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 0.6 | 1.7 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
| 0.6 | 109.6 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
| 0.6 | 2.2 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 0.6 | 3.3 | GO:0039552 | RIG-I binding(GO:0039552) |
| 0.6 | 1.7 | GO:0033749 | histone demethylase activity (H3-R2 specific)(GO:0033746) histone demethylase activity (H4-R3 specific)(GO:0033749) |
| 0.5 | 1.1 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
| 0.5 | 35.7 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
| 0.5 | 2.7 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
| 0.5 | 2.1 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
| 0.5 | 3.2 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
| 0.5 | 6.3 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
| 0.5 | 31.9 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
| 0.5 | 2.1 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
| 0.5 | 1.6 | GO:0061665 | SUMO ligase activity(GO:0061665) |
| 0.5 | 7.3 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 0.5 | 7.3 | GO:0048038 | quinone binding(GO:0048038) |
| 0.5 | 4.2 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
| 0.5 | 2.1 | GO:0004875 | complement receptor activity(GO:0004875) |
| 0.5 | 5.1 | GO:0031014 | troponin T binding(GO:0031014) |
| 0.5 | 13.8 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
| 0.5 | 1.0 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
| 0.5 | 5.0 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
| 0.5 | 3.5 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
| 0.5 | 1.5 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
| 0.5 | 5.9 | GO:0070700 | BMP receptor binding(GO:0070700) |
| 0.5 | 1.5 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
| 0.5 | 2.0 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
| 0.5 | 1.5 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
| 0.5 | 9.8 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
| 0.5 | 1.5 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
| 0.5 | 1.5 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 0.5 | 1.0 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
| 0.5 | 8.7 | GO:0070513 | death domain binding(GO:0070513) |
| 0.5 | 1.4 | GO:0047322 | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity(GO:0047322) [acetyl-CoA carboxylase] kinase activity(GO:0050405) |
| 0.5 | 1.4 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
| 0.5 | 1.4 | GO:0004418 | hydroxymethylbilane synthase activity(GO:0004418) |
| 0.5 | 1.0 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
| 0.5 | 2.9 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
| 0.5 | 6.2 | GO:0031419 | cobalamin binding(GO:0031419) |
| 0.5 | 0.5 | GO:0019826 | oxygen sensor activity(GO:0019826) |
| 0.5 | 9.4 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
| 0.5 | 1.9 | GO:0047298 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
| 0.5 | 3.7 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
| 0.5 | 5.5 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
| 0.5 | 8.3 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.5 | 1.4 | GO:0042019 | interleukin-23 binding(GO:0042019) interleukin-23 receptor activity(GO:0042020) |
| 0.5 | 4.6 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
| 0.5 | 2.7 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
| 0.4 | 3.6 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
| 0.4 | 12.9 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
| 0.4 | 8.0 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
| 0.4 | 2.2 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
| 0.4 | 1.3 | GO:0008267 | poly-glutamine tract binding(GO:0008267) |
| 0.4 | 0.9 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
| 0.4 | 3.6 | GO:0016531 | copper chaperone activity(GO:0016531) |
| 0.4 | 2.7 | GO:0008142 | oxysterol binding(GO:0008142) |
| 0.4 | 8.4 | GO:0016849 | phosphorus-oxygen lyase activity(GO:0016849) |
| 0.4 | 8.3 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
| 0.4 | 1.3 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
| 0.4 | 30.3 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
| 0.4 | 4.8 | GO:0043176 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
| 0.4 | 1.7 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
| 0.4 | 1.7 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
| 0.4 | 14.1 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
| 0.4 | 9.2 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
| 0.4 | 5.3 | GO:0005542 | folic acid binding(GO:0005542) |
| 0.4 | 0.8 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
| 0.4 | 1.6 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 0.4 | 2.8 | GO:0030274 | LIM domain binding(GO:0030274) |
| 0.4 | 6.8 | GO:0001223 | transcription coactivator binding(GO:0001223) |
| 0.4 | 1.6 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
| 0.4 | 16.4 | GO:0004407 | histone deacetylase activity(GO:0004407) |
| 0.4 | 10.8 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
| 0.4 | 1.6 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
| 0.4 | 2.4 | GO:0005217 | intracellular ligand-gated ion channel activity(GO:0005217) |
| 0.4 | 5.1 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.4 | 1.2 | GO:0043035 | chromatin insulator sequence binding(GO:0043035) |
| 0.4 | 3.5 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
| 0.4 | 3.1 | GO:0070411 | I-SMAD binding(GO:0070411) |
| 0.4 | 1.1 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
| 0.4 | 0.4 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
| 0.4 | 1.9 | GO:0015116 | secondary active sulfate transmembrane transporter activity(GO:0008271) sulfate transmembrane transporter activity(GO:0015116) |
| 0.4 | 24.2 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
| 0.4 | 0.4 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
| 0.4 | 3.7 | GO:0005243 | gap junction channel activity(GO:0005243) |
| 0.4 | 6.3 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
| 0.4 | 1.1 | GO:0000405 | bubble DNA binding(GO:0000405) |
| 0.4 | 5.2 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
| 0.4 | 15.3 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
| 0.4 | 1.1 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
| 0.4 | 2.9 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
| 0.4 | 1.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.4 | 0.7 | GO:0031781 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
| 0.4 | 1.8 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
| 0.4 | 0.7 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
| 0.3 | 1.0 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
| 0.3 | 4.5 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
| 0.3 | 3.1 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
| 0.3 | 3.8 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 0.3 | 0.7 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
| 0.3 | 1.0 | GO:0016497 | substance K receptor activity(GO:0016497) |
| 0.3 | 1.0 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
| 0.3 | 1.0 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
| 0.3 | 1.0 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
| 0.3 | 0.7 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 0.3 | 3.1 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
| 0.3 | 2.0 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
| 0.3 | 3.4 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
| 0.3 | 6.7 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.3 | 3.0 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
| 0.3 | 4.7 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 0.3 | 2.4 | GO:0036122 | BMP binding(GO:0036122) |
| 0.3 | 9.0 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
| 0.3 | 13.0 | GO:0005272 | sodium channel activity(GO:0005272) |
| 0.3 | 1.7 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
| 0.3 | 1.3 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
| 0.3 | 2.0 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
| 0.3 | 4.6 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 0.3 | 2.3 | GO:0050693 | LBD domain binding(GO:0050693) |
| 0.3 | 0.6 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
| 0.3 | 4.4 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
| 0.3 | 2.2 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
| 0.3 | 3.4 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.3 | 2.7 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
| 0.3 | 1.5 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
| 0.3 | 1.8 | GO:0004359 | glutaminase activity(GO:0004359) |
| 0.3 | 7.4 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
| 0.3 | 9.5 | GO:0030332 | cyclin binding(GO:0030332) |
| 0.3 | 1.2 | GO:0004925 | prolactin receptor activity(GO:0004925) |
| 0.3 | 0.6 | GO:0070052 | collagen V binding(GO:0070052) |
| 0.3 | 1.4 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
| 0.3 | 1.2 | GO:0047708 | biotinidase activity(GO:0047708) |
| 0.3 | 1.4 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
| 0.3 | 0.9 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
| 0.3 | 1.7 | GO:0048406 | nerve growth factor binding(GO:0048406) |
| 0.3 | 4.8 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
| 0.3 | 1.1 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
| 0.3 | 2.7 | GO:0005372 | water transmembrane transporter activity(GO:0005372) water channel activity(GO:0015250) |
| 0.3 | 3.0 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
| 0.3 | 3.8 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 0.3 | 1.1 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) |
| 0.3 | 4.3 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
| 0.3 | 5.6 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.3 | 1.1 | GO:0035197 | siRNA binding(GO:0035197) |
| 0.3 | 8.2 | GO:0042805 | actinin binding(GO:0042805) |
| 0.3 | 0.8 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
| 0.3 | 5.8 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
| 0.3 | 1.6 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
| 0.3 | 0.5 | GO:0042008 | interleukin-18 receptor activity(GO:0042008) |
| 0.3 | 3.1 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
| 0.3 | 1.0 | GO:0070728 | leucine binding(GO:0070728) |
| 0.3 | 110.5 | GO:0000987 | core promoter proximal region sequence-specific DNA binding(GO:0000987) |
| 0.2 | 1.2 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
| 0.2 | 0.7 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
| 0.2 | 2.0 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
| 0.2 | 0.7 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
| 0.2 | 0.5 | GO:0008432 | JUN kinase binding(GO:0008432) |
| 0.2 | 0.7 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
| 0.2 | 2.9 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) |
| 0.2 | 0.7 | GO:0098808 | mRNA cap binding(GO:0098808) |
| 0.2 | 10.8 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
| 0.2 | 0.7 | GO:0033765 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) cholestenone 5-alpha-reductase activity(GO:0047751) |
| 0.2 | 0.9 | GO:0031685 | adenosine receptor binding(GO:0031685) |
| 0.2 | 0.7 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
| 0.2 | 1.1 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
| 0.2 | 0.9 | GO:0035939 | microsatellite binding(GO:0035939) |
| 0.2 | 6.1 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.2 | 5.9 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
| 0.2 | 4.9 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
| 0.2 | 2.9 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
| 0.2 | 1.3 | GO:0005047 | signal recognition particle binding(GO:0005047) |
| 0.2 | 1.8 | GO:0019789 | SUMO transferase activity(GO:0019789) |
| 0.2 | 10.8 | GO:0020037 | heme binding(GO:0020037) |
| 0.2 | 0.6 | GO:0070039 | rRNA (guanosine-2'-O-)-methyltransferase activity(GO:0070039) |
| 0.2 | 1.3 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
| 0.2 | 4.9 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
| 0.2 | 1.5 | GO:0051400 | BH domain binding(GO:0051400) |
| 0.2 | 14.3 | GO:0017022 | myosin binding(GO:0017022) |
| 0.2 | 2.7 | GO:0004697 | protein kinase C activity(GO:0004697) |
| 0.2 | 0.6 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
| 0.2 | 2.7 | GO:0005112 | Notch binding(GO:0005112) |
| 0.2 | 5.8 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
| 0.2 | 0.8 | GO:0004356 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
| 0.2 | 2.9 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
| 0.2 | 0.6 | GO:0050254 | rhodopsin kinase activity(GO:0050254) |
| 0.2 | 1.0 | GO:0009881 | photoreceptor activity(GO:0009881) |
| 0.2 | 1.8 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
| 0.2 | 5.2 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
| 0.2 | 1.6 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
| 0.2 | 0.8 | GO:0004087 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
| 0.2 | 0.8 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
| 0.2 | 2.9 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
| 0.2 | 1.0 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 0.2 | 5.5 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 0.2 | 0.9 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
| 0.2 | 1.1 | GO:0031996 | thioesterase binding(GO:0031996) |
| 0.2 | 3.0 | GO:0015645 | fatty acid ligase activity(GO:0015645) |
| 0.2 | 0.7 | GO:0032184 | SUMO polymer binding(GO:0032184) |
| 0.2 | 0.6 | GO:0033142 | progesterone receptor binding(GO:0033142) |
| 0.2 | 4.8 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
| 0.2 | 0.5 | GO:0004577 | N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity(GO:0004577) |
| 0.2 | 0.2 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
| 0.2 | 0.9 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
| 0.2 | 1.8 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
| 0.2 | 4.5 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
| 0.2 | 0.7 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
| 0.2 | 1.0 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
| 0.2 | 0.5 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
| 0.2 | 1.2 | GO:0019213 | deacetylase activity(GO:0019213) |
| 0.2 | 0.5 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 0.2 | 1.7 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.2 | 4.3 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.2 | 1.0 | GO:0019863 | IgE binding(GO:0019863) |
| 0.2 | 0.2 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
| 0.2 | 1.0 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
| 0.2 | 1.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 0.2 | 11.4 | GO:0008013 | beta-catenin binding(GO:0008013) |
| 0.2 | 1.8 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
| 0.2 | 48.6 | GO:0005096 | GTPase activator activity(GO:0005096) |
| 0.2 | 1.1 | GO:0004137 | deoxycytidine kinase activity(GO:0004137) |
| 0.1 | 5.1 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
| 0.1 | 0.7 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
| 0.1 | 1.3 | GO:0042056 | chemoattractant activity(GO:0042056) |
| 0.1 | 1.1 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
| 0.1 | 1.5 | GO:0005537 | mannose binding(GO:0005537) |
| 0.1 | 0.4 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 0.1 | 6.1 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
| 0.1 | 0.4 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
| 0.1 | 0.3 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
| 0.1 | 1.2 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
| 0.1 | 0.5 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
| 0.1 | 3.8 | GO:0030331 | estrogen receptor binding(GO:0030331) |
| 0.1 | 5.0 | GO:0008066 | glutamate receptor activity(GO:0008066) |
| 0.1 | 1.2 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
| 0.1 | 3.0 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
| 0.1 | 0.3 | GO:0039706 | co-receptor binding(GO:0039706) |
| 0.1 | 15.5 | GO:0005178 | integrin binding(GO:0005178) |
| 0.1 | 0.6 | GO:0004962 | endothelin receptor activity(GO:0004962) |
| 0.1 | 0.4 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
| 0.1 | 0.4 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
| 0.1 | 0.2 | GO:0015205 | nucleobase transmembrane transporter activity(GO:0015205) |
| 0.1 | 1.2 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
| 0.1 | 0.4 | GO:0071566 | UFM1 activating enzyme activity(GO:0071566) |
| 0.1 | 0.7 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
| 0.1 | 2.7 | GO:0032451 | demethylase activity(GO:0032451) |
| 0.1 | 2.8 | GO:0005109 | frizzled binding(GO:0005109) |
| 0.1 | 1.4 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
| 0.1 | 2.3 | GO:0046875 | ephrin receptor binding(GO:0046875) |
| 0.1 | 0.7 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 0.1 | 1.5 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
| 0.1 | 0.6 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
| 0.1 | 0.4 | GO:0001222 | transcription corepressor binding(GO:0001222) |
| 0.1 | 2.3 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.1 | 0.3 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
| 0.1 | 0.7 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
| 0.1 | 1.1 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
| 0.1 | 0.4 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
| 0.1 | 0.3 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 0.1 | 0.7 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
| 0.1 | 0.6 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
| 0.1 | 0.4 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
| 0.1 | 0.3 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
| 0.1 | 2.6 | GO:0004364 | glutathione transferase activity(GO:0004364) |
| 0.1 | 7.6 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
| 0.1 | 1.1 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.1 | 0.2 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
| 0.1 | 1.6 | GO:0004866 | endopeptidase inhibitor activity(GO:0004866) |
| 0.1 | 0.6 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
| 0.1 | 0.3 | GO:0004638 | phosphoribosylaminoimidazole carboxylase activity(GO:0004638) phosphoribosylaminoimidazolesuccinocarboxamide synthase activity(GO:0004639) |
| 0.1 | 0.7 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
| 0.1 | 0.3 | GO:0004966 | galanin receptor activity(GO:0004966) |
| 0.1 | 6.6 | GO:0004713 | protein tyrosine kinase activity(GO:0004713) |
| 0.1 | 0.2 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
| 0.1 | 0.9 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
| 0.1 | 0.2 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
| 0.1 | 2.4 | GO:0030295 | protein kinase activator activity(GO:0030295) |
| 0.1 | 0.2 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
| 0.1 | 1.0 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
| 0.1 | 0.5 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
| 0.1 | 0.2 | GO:0052810 | 1-phosphatidylinositol-5-kinase activity(GO:0052810) |
| 0.1 | 0.6 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
| 0.1 | 0.5 | GO:0051059 | NF-kappaB binding(GO:0051059) |
| 0.1 | 0.6 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 0.1 | 1.4 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 0.1 | 5.0 | GO:0008083 | growth factor activity(GO:0008083) |
| 0.1 | 1.0 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
| 0.1 | 0.4 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
| 0.1 | 0.3 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
| 0.0 | 0.2 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
| 0.0 | 0.4 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
| 0.0 | 0.3 | GO:0035198 | miRNA binding(GO:0035198) |
| 0.0 | 1.3 | GO:0042162 | telomeric DNA binding(GO:0042162) |
| 0.0 | 0.2 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
| 0.0 | 1.4 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
| 0.0 | 0.1 | GO:0042166 | acetylcholine binding(GO:0042166) |
| 0.0 | 1.3 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
| 0.0 | 0.1 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
| 0.0 | 0.3 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
| 0.0 | 0.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
| 0.0 | 0.2 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.0 | 0.3 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
| 0.0 | 0.3 | GO:0050811 | GABA receptor binding(GO:0050811) |
| 0.0 | 0.1 | GO:0004960 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
| 0.0 | 0.0 | GO:0055100 | adiponectin binding(GO:0055100) |
| 0.0 | 0.4 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
| 0.0 | 0.2 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
| 0.0 | 0.1 | GO:0042947 | glucoside transmembrane transporter activity(GO:0042947) |
| 0.0 | 0.3 | GO:0015144 | carbohydrate transmembrane transporter activity(GO:0015144) carbohydrate transporter activity(GO:1901476) |
| 0.0 | 0.2 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
| 0.0 | 0.2 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.0 | 0.4 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 0.0 | 0.1 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
| 0.0 | 0.2 | GO:0071837 | HMG box domain binding(GO:0071837) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.1 | 8.2 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
| 3.2 | 3.2 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 3.1 | 6.3 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
| 2.7 | 2.7 | PID S1P S1P2 PATHWAY | S1P2 pathway |
| 2.4 | 116.0 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 2.2 | 8.8 | PID IL3 PATHWAY | IL3-mediated signaling events |
| 2.0 | 212.1 | PID IL4 2PATHWAY | IL4-mediated signaling events |
| 1.8 | 43.7 | ST G ALPHA S PATHWAY | G alpha s Pathway |
| 1.8 | 137.6 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
| 1.7 | 5.2 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
| 1.7 | 6.8 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
| 1.6 | 19.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
| 1.6 | 114.2 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 1.4 | 2.8 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
| 1.4 | 13.6 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
| 1.3 | 55.0 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
| 1.3 | 89.8 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
| 1.2 | 1.2 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
| 1.1 | 35.6 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
| 1.1 | 7.9 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
| 1.1 | 17.7 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 1.1 | 1.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
| 1.1 | 19.1 | PID EPO PATHWAY | EPO signaling pathway |
| 1.1 | 13.7 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
| 0.9 | 3.8 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.9 | 39.1 | PID BCR 5PATHWAY | BCR signaling pathway |
| 0.9 | 243.1 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.9 | 11.0 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
| 0.9 | 22.4 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.9 | 8.6 | PID CONE PATHWAY | Visual signal transduction: Cones |
| 0.7 | 1.5 | ST GAQ PATHWAY | G alpha q Pathway |
| 0.7 | 3.0 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
| 0.7 | 9.2 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.7 | 2.1 | ST STAT3 PATHWAY | STAT3 Pathway |
| 0.7 | 13.4 | PID IL2 1PATHWAY | IL2-mediated signaling events |
| 0.7 | 1.4 | PID S1P S1P1 PATHWAY | S1P1 pathway |
| 0.7 | 43.9 | PID BMP PATHWAY | BMP receptor signaling |
| 0.7 | 6.1 | PID NOTCH PATHWAY | Notch signaling pathway |
| 0.7 | 116.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.7 | 6.6 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
| 0.6 | 3.9 | PID IL5 PATHWAY | IL5-mediated signaling events |
| 0.6 | 0.6 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.6 | 47.9 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
| 0.6 | 28.0 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
| 0.6 | 33.8 | PID ARF6 PATHWAY | Arf6 signaling events |
| 0.6 | 14.2 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
| 0.6 | 69.9 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
| 0.5 | 24.3 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.5 | 17.6 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.5 | 12.5 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.5 | 6.5 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
| 0.5 | 0.5 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
| 0.5 | 22.7 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.5 | 12.2 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.5 | 15.0 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
| 0.5 | 15.2 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 0.4 | 4.0 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
| 0.4 | 36.9 | PID CMYB PATHWAY | C-MYB transcription factor network |
| 0.4 | 16.0 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.4 | 13.8 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
| 0.4 | 8.8 | ST GA12 PATHWAY | G alpha 12 Pathway |
| 0.4 | 18.0 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
| 0.4 | 9.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.4 | 2.1 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
| 0.4 | 5.8 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
| 0.4 | 1.6 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 0.4 | 15.1 | PID AP1 PATHWAY | AP-1 transcription factor network |
| 0.4 | 5.2 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
| 0.4 | 1.5 | PID IL12 2PATHWAY | IL12-mediated signaling events |
| 0.4 | 6.1 | PID ALK1 PATHWAY | ALK1 signaling events |
| 0.4 | 2.8 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
| 0.4 | 2.8 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
| 0.3 | 2.4 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
| 0.3 | 16.1 | PID MTOR 4PATHWAY | mTOR signaling pathway |
| 0.3 | 7.1 | SIG CHEMOTAXIS | Genes related to chemotaxis |
| 0.3 | 3.4 | PID IL27 PATHWAY | IL27-mediated signaling events |
| 0.3 | 15.2 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
| 0.3 | 3.3 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
| 0.3 | 0.9 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 0.3 | 4.9 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
| 0.3 | 4.8 | PID EPHA FWDPATHWAY | EPHA forward signaling |
| 0.3 | 11.7 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
| 0.3 | 6.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.2 | 1.9 | PID CD40 PATHWAY | CD40/CD40L signaling |
| 0.2 | 1.4 | ST GA13 PATHWAY | G alpha 13 Pathway |
| 0.2 | 3.7 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.2 | 1.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.2 | 3.7 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.2 | 1.4 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
| 0.2 | 5.2 | PID IL1 PATHWAY | IL1-mediated signaling events |
| 0.2 | 2.2 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
| 0.2 | 1.9 | PID IGF1 PATHWAY | IGF1 pathway |
| 0.2 | 3.9 | PID INSULIN PATHWAY | Insulin Pathway |
| 0.2 | 6.2 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
| 0.2 | 0.6 | PID S1P S1P4 PATHWAY | S1P4 pathway |
| 0.2 | 2.4 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
| 0.2 | 3.4 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
| 0.2 | 1.8 | PID ALK2 PATHWAY | ALK2 signaling events |
| 0.2 | 2.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
| 0.2 | 4.9 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
| 0.2 | 8.9 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.2 | 5.6 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
| 0.2 | 2.1 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.2 | 0.6 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
| 0.2 | 4.9 | PID ATM PATHWAY | ATM pathway |
| 0.1 | 1.4 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
| 0.1 | 8.4 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 0.1 | 0.6 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.1 | 0.9 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
| 0.1 | 0.5 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
| 0.1 | 3.6 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
| 0.1 | 6.6 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
| 0.1 | 0.5 | PID MYC PATHWAY | C-MYC pathway |
| 0.1 | 0.7 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
| 0.1 | 2.1 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
| 0.1 | 1.9 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
| 0.1 | 0.3 | NABA COLLAGENS | Genes encoding collagen proteins |
| 0.1 | 1.6 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.0 | 1.0 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 0.0 | 2.1 | PID LKB1 PATHWAY | LKB1 signaling events |
| 0.0 | 0.2 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
| 0.0 | 0.6 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.0 | 0.8 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 0.0 | 0.3 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
| 0.0 | 0.1 | PID IL23 PATHWAY | IL23-mediated signaling events |
| 0.0 | 0.2 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 0.0 | 0.4 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.0 | 0.3 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
| 0.0 | 3.4 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
| 0.0 | 0.2 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 8.9 | 186.3 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
| 4.4 | 4.4 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
| 4.1 | 45.2 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
| 4.1 | 78.1 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
| 3.6 | 3.6 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
| 3.3 | 59.7 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
| 3.1 | 9.4 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
| 3.1 | 31.0 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
| 3.1 | 21.4 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
| 2.9 | 62.9 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 2.5 | 50.5 | REACTOME DEFENSINS | Genes involved in Defensins |
| 2.2 | 31.4 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
| 2.2 | 186.5 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 2.1 | 8.2 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
| 2.0 | 2.0 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
| 1.9 | 34.6 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
| 1.9 | 3.8 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 1.8 | 16.6 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 1.8 | 28.7 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
| 1.8 | 8.9 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
| 1.7 | 31.0 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 1.7 | 6.9 | REACTOME PI3K AKT ACTIVATION | Genes involved in PI3K/AKT activation |
| 1.7 | 35.8 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 1.7 | 61.3 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 1.6 | 26.2 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 1.5 | 24.4 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
| 1.4 | 53.1 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
| 1.3 | 13.5 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
| 1.3 | 30.3 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
| 1.2 | 9.8 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
| 1.2 | 77.5 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
| 1.2 | 35.7 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 1.2 | 24.7 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
| 1.2 | 13.9 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
| 1.2 | 26.5 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 1.1 | 5.7 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
| 1.1 | 48.6 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
| 1.1 | 2.1 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
| 1.1 | 11.7 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 1.1 | 23.3 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
| 1.1 | 25.3 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
| 1.0 | 6.2 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
| 1.0 | 17.5 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
| 0.9 | 54.8 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
| 0.9 | 8.5 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
| 0.9 | 29.5 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
| 0.9 | 1.8 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
| 0.9 | 8.8 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
| 0.9 | 13.8 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.9 | 8.6 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
| 0.9 | 0.9 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
| 0.8 | 16.1 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
| 0.8 | 6.8 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
| 0.8 | 6.6 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
| 0.8 | 26.6 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.8 | 11.0 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
| 0.8 | 18.2 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.7 | 3.0 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
| 0.7 | 22.7 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
| 0.7 | 41.4 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.7 | 2.1 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
| 0.7 | 4.9 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.7 | 28.1 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.7 | 34.3 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
| 0.7 | 69.8 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.7 | 8.6 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
| 0.7 | 11.9 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.6 | 6.5 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 0.6 | 7.6 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
| 0.6 | 8.9 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
| 0.6 | 3.8 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
| 0.6 | 1.9 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
| 0.6 | 8.6 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
| 0.6 | 1.8 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
| 0.6 | 6.7 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
| 0.6 | 3.0 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
| 0.6 | 14.7 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
| 0.6 | 8.7 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
| 0.6 | 27.1 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
| 0.6 | 55.3 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.6 | 3.4 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
| 0.5 | 12.6 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
| 0.5 | 47.3 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.5 | 0.5 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
| 0.5 | 24.5 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
| 0.5 | 3.7 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
| 0.5 | 10.5 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
| 0.5 | 11.5 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.5 | 6.2 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
| 0.5 | 23.2 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
| 0.5 | 8.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.5 | 17.3 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
| 0.5 | 1.0 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
| 0.5 | 29.4 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 0.5 | 22.2 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
| 0.5 | 4.9 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
| 0.5 | 10.0 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.5 | 2.8 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
| 0.5 | 19.4 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.5 | 0.9 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
| 0.5 | 3.7 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
| 0.5 | 9.6 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
| 0.5 | 11.8 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
| 0.4 | 3.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
| 0.4 | 11.6 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
| 0.4 | 12.0 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 0.4 | 1.2 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
| 0.4 | 20.9 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
| 0.4 | 20.3 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
| 0.4 | 7.1 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.4 | 6.3 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
| 0.4 | 0.4 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
| 0.4 | 4.1 | REACTOME OPSINS | Genes involved in Opsins |
| 0.3 | 1.7 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
| 0.3 | 16.6 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
| 0.3 | 5.5 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.3 | 22.7 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
| 0.3 | 4.7 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
| 0.3 | 0.6 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 0.3 | 6.0 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.3 | 3.1 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
| 0.3 | 7.1 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
| 0.3 | 35.1 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
| 0.3 | 3.8 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
| 0.2 | 18.5 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
| 0.2 | 0.7 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
| 0.2 | 1.5 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
| 0.2 | 1.7 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 0.2 | 16.4 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.2 | 3.6 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
| 0.2 | 6.4 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.2 | 5.2 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
| 0.2 | 1.7 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
| 0.2 | 1.9 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
| 0.2 | 6.9 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.2 | 0.6 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
| 0.2 | 4.1 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
| 0.2 | 8.5 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
| 0.2 | 1.6 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
| 0.2 | 1.1 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
| 0.2 | 13.5 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
| 0.2 | 1.4 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
| 0.2 | 0.5 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
| 0.2 | 0.8 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
| 0.2 | 2.9 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
| 0.1 | 2.8 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
| 0.1 | 1.3 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
| 0.1 | 10.6 | REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE | Genes involved in MyD88:Mal cascade initiated on plasma membrane |
| 0.1 | 0.6 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
| 0.1 | 1.5 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
| 0.1 | 1.2 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
| 0.1 | 0.4 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
| 0.1 | 1.4 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 0.1 | 1.0 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
| 0.1 | 1.5 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.1 | 1.7 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 0.1 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
| 0.1 | 2.4 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
| 0.1 | 0.3 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
| 0.1 | 0.7 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
| 0.1 | 0.9 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
| 0.1 | 1.1 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
| 0.1 | 0.3 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
| 0.1 | 0.7 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
| 0.0 | 3.2 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.0 | 4.6 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
| 0.0 | 0.3 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
| 0.0 | 0.3 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
| 0.0 | 2.0 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
| 0.0 | 0.4 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
| 0.0 | 0.7 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
| 0.0 | 3.8 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.0 | 0.7 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.0 | 0.3 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
| 0.0 | 0.1 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
| 0.0 | 0.3 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
| 0.0 | 0.5 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |